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ABSTRACT 
 
Synthetic polypeptides are of great importance in biomedical applications as they are 
directly modelled on natural proteins and can mimic their functions in biological systems.  
Thus, synthetic polypeptides display properties such as biocompatibility, biodegradability, 
bioavailability, bioadhesion and could find applications in drug delivery, tissue 
engineering, implants, therapeutics. The availability of wide range of functionality of the 
synthetic polypeptides arising from the vast pool of natural and non-natural amino acids has 
been used to modify and to impart new functionalities to the synthetic materials such as 
organic/inorganic nanoparticles, surfaces, synthetic polymeric architectures, films. This 
new class of hybrid materials with enhanced biocompatibility are advantageous over their 
constituent components and show promising candidature in advanced biomedical 
applications.   
N-carboxyanhydride Ring Opening Polymerization (NCA-ROP) is a lucrative technique to 
synthesize polypeptides with controlled molecular weights and narrow polydispersities. 
Surface intiated N-carboxyanhydride ring opening polymerization (SI-NCA-ROP) by an 
immobilized intiator has been investigated  to teather  synthetic polypeptides onto the 
desired material surfaces. SI-NCA-ROP has been employed from silica nanoparticle 
surfaces to engineer synthetic polypeptide grafted smart hybrid materials capable of 
changing microscopic properties according to the changes in pH of the external micro-
environment. These silica polypeptide hybrids have shown their applicability in pH 
responsive cargo release systems. Similarly, surface grafted synthetic polypeptides have 
been used to modify and improve dispersion properties of iron-oxide magnetic 
nanoparticles useful in imaging and drug delivery applications. Grafting of highly 
hydrophilic glycosylated polypeptides have shown improved aqueous dispersion properties 
of these inorganic nanoparticles useful for  MRI imaging and bio-recognition.   In an 
extended study, polypeptides comprising two amino acids have been grafted from iron 
oxide nanoparticle surfaces to engineer new hybrids with excellent aqueous dispersibility 
and siRNA vector ability. These co-polypeptide grafted nanoparticle hybrids  shown to 
retain their bio-recognition ability besides improving aqueous dispersibilty and imparting 
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siRNA vectorability, which highlights their applicability as theranostics. In summary,  we 
have presented novel polypeptide hybrid materials by SI-NCA-ROP and their advanced 
biomedical applications.  
ix 
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1.1 Introduction 
 
In recent years tremendous research activities targeting the development of nanotechnology 
has revolutionized the diagnosis and treatment of tumour, pain and infectious diseases.
1
 
These advanced therapeutics harness the opportunities provided by nanoparticles arising 
from their unique properties to monitor the drug kinetics and to increase the drug efficacy 
by improving drug solubility, extending half life and by reducing immunogenicity.
2-5
  
Nanoparticles that have been studied for biomedical applications range from noble metals
6,7
 
like Ag, Au to semiconductors
8,9
 like CdS, ZnS, SiO2, TiO2 and magnetic compounds
10,11,12
 
like Fe2O3/Fe3O4, CoFe2O3, etc. These inorganic nanoparticles offer high surface to volume 
ratios and size dependent unique optical, magnetic, electronic, or catalytic properties.
13
 
Another class, organic nanoparticles or soft nanoparticles, which include liposome
14
, 
polymeric micelles
15
 and nanogels
16
 offer features like wide range of functionality for 
conjugation of targeting ligands and ability of carrying both hydrophobic and hydrophilic 
payload into respective components of the self assembly structures.
17
  
Organic/inorganic hybrid systems are interesting “intermediate” class and often display 
unique features compared to the constituting component alone.  Compared to conventional 
materials enhanced performance can often be achieved by the systematic tuning of the 
functionalities of the constituting components of hybrid materials.
18,19
 This opens a 
potential for new advanced applications such as imaging
20
, sensors
21
, drug delivery
22
, etc.  
Organic components such as polymers have been widely used to form inorganic-polymer 
hybrids to improve dispersion, biocompatibility and functional properties of inorganic 
materials.
23
 Inorganic-polymer hybrids have been synthesized by coating polymer onto an 
inorganic nanoparticle surface by physical, chemical, ionic and adsorption methods.
24
 
Chemically tethered polymer inorganic hybrids are synthesized either by anchoring pre-
formed, end functional polymers onto functional inorganic surfaces by using known 
coupling chemistry (grafting onto)
25,26
 or by polymerization of monomers from inorganic 
surfaces by immobilized initiators (grafting from).
27
 In the later case, the grafting density of 
polymer chains per square unit surface area is higher due to lower sterical hindrance for 
monomers to reach the growing polymer site (Fig.: 1.1). 
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Figure 1.1: Hybrid material synthesis by ‘grafting onto’ (a) and ‘grafting from’ (b) 
approach. 
 
Various polymerization methods have been developed to design inorganic-polymer hybrids 
by the ‘grafting from’ approach, in particular conventional controlled radical 
polymerization methods such as atom transfer radical polymerization (ATRP)
28
, reversible 
addition-fragmentation chain transfer polymerization (RAFT)
29
, nitroxide mediated 
polymerization (NMP)
30,31
 and ring opening polymerization (ROP)
32,33
.  Excellent control 
over the polymer thickness and the large choice of readily available monomers with a range 
of functionalities make controlled radical polymerization techniques of vinyl monomers 
advantageous over other polymerizations from inorganic surfaces.  However the 
corresponding polymers have a disadvantage of not being biodegradable and in some cases 
not biocompatible, which is detrimental for their application in some biomedical devices. 
Hybrid materials constituting biocompatible and biodegradable organic component derived 
4 
 
from renewable resources (e.g. amino acids, carbohydrates, lactons, lactides) can overcome 
these drawbacks of synthetic vinyl polymers.
34
  The use of polypeptides for the 
functionalization of inorganic nanoparticles offers biocompatibility in conjugation with 
diverse functionality dependent on the particular amino acid chosen from a pool of natural 
and non-natural amino acids. Consequently, in recent times increasing attention has been 
given by research community to investigate synthetic polypeptides as building blocks for 
functional hybrid materials for advanced biomedical applications. ‘Surface grafting’ of the 
synthetic polypeptides using α-amino acid N-carboxyanhydride ring opening 
polymerization (NCA-ROP) is the most commonly used technique to decorate surfaces 
with synthetic polypeptide brushes.  
 
1.2 Synthetic Polypeptides 
 
Synthetic peptides or poly(amino acid)s are polymers derived from the 20 natural and many 
non-natural amino acids. Due to their structural similarities to natural proteins and peptides, 
these materials can address the challenges of biocompatibility and biodegradability 
associated with fully synthetic polymers. Moreover, these synthetic polypeptides may adopt 
stable secondary structures like helices, sheets and random coil through non-covalent 
interactions leading to novel self-assembled supramolecular structures.
35
 Additionally, 
these polypeptides can reveal a transition in response to the change in local environment 
like temperature, pH, salt etc. depending on the side chain functionality of constituting 
amino acids.
36,37,38
 All these advantages make polypeptide based materials interesting for 
the use in various biomedical applications such as sensors, drug delivery, tissue engineering 
among others.
39
 Two synthetic approaches, namely solid phase peptide synthesis (SPPS) 
and α-amino acid N-carboxyanhydride ring opening polymerization (NCA-ROP) are 
employed to synthesize synthetic polypeptides. Both synthetic techniques offer advantages 
and limitations over the other. Polypeptide with well defined and precisely controlled 
amino acid sequence can be obtained by SPPS method via step-wise coupling of protected 
amino acid on a solid support.
40
 Nowadays, SPPS is a routine and robust method to 
synthesize sequenced polypeptides with small and medium size (up to 50 amino acids) with 
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high yield and purities on laboratory scale. However, incomplete coupling steps, side 
reactions, low yield and increased difficulty in purification are drawbacks in the synthesis 
of peptides with increasing chain lengths.
41
 In comparison, high molecular weight homo 
and copolypeptides with unspecific sequences can be synthesized by NCA ring opening 
polymerization. Over a century after the first report of amino acid anhydride synthesis by 
Leuches in 1906, many advances has been made in the NCA-ROP technique leading to 
precise control over the structure, molecular weight, narrow polydispersities, and ease of 
synthesis.
42,43,44,45
  
 
1.3 N-carboxyanhydride Ring Opening Polymerization 
 
Herman Leuches in early 1906, reported the first synthesis of an amino acid NCA and its 
ring opening polymerization.
46
 In the publications reported in 1906 and 1907, he called the 
polymerization products of NCA’s ‘anhydride form of amino acid’. From its amorphous 
character and lack of sharp melting point, later in 1908 he concluded the products being 
polymeric modifications of α-lactum. After 1921, a definite role of NCA as a monomer to 
synthesize high molar mass polypeptides by ring opening polymerization using water, 
alcohol and primary amine as initiators was demonstrated by Curtius
47
, Wessely
48
 and their 
co-workers. NCAs of α-amino acids can also be synthesized by an alternative method by 
treatment of amino acids or their derivatives with phosgene. (Fuchs-Fartig method, 
Scheme: 1.1).
49
 Handling of harmful phosgene could be avoided by use of alternatives like 
triphosgene, diphosgene, di-tert-butyltricarbonate, i.e. reagents capable of in situ generation 
of phosgene in an anhydride ring closing reaction.
50
 
OH
O
R
NH2 HN
O
R
O
O
Cl Cl
O
 
Scheme1.1: N-carboxyanhydride synthesis by Fuchs-Farthing method.
49
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1.3.1 Mechanistic insight into NCA-ROP 
 
Before reports of living ring opening polymerization of NCA by Deming
42
, most 
researchers agreed on two possible pathways for NCA ring opening polymerization, i.e 
Normal Amine Mechanism (NAM) and Activated Monomer Mechanism (AMM). A variety 
of nucleophiles such as primary amines and bases such as metal alkoxides, tertiary amines 
can be used for initiating ROP of NCA. The NAM is attributed to strong nucleophiles 
whereas AMM is attributed to strong bases. For secondary amine as NCA-ROP initiating 
moiety, coexistence of both mechanisms is proposed.  
 
1.3.1.1 Normal Amine Mechanism (NAM) 
 
Non-ionic initiators bearing at least one free hydrogen atom such as primary amines, 
secondary amines, alcohols and water are proposed to initiate NCA-ROP by NAM. 
Initiation occurs by nucleophilic attack of the base on the C5 carbonyl of the NCA to give 
an intermediate unstable carbamic acid further decarboxylating to produce a new free 
amino group, which sequentially attacks a new NCA monomer (Scheme 1.2). The higher 
nucleophilicity of the primary amines over those of the polymer amino groups results in a 
faster initiation than propagation rate leading to polypeptides with low polydispersities. 
Carbamic acid-CO2 equilibrium, solvent and presence of water and other impurities may 
cause deviation from the living nature of polymerization. An intermediate carbamic acid 
can form a salt with the amino group of the propagating chains, which influences the 
reaction kinetics resulting in higher than first order reaction kinetics. 
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Scheme 1.2: Normal Amine Mechanism for NCA Polymerization. 
 
 1.3.1.2 Activated Amine Mechanism (AMM) 
 
Ballard and co-workers
51
 first proposed this mechanism to explain tertiary amine initiated 
NCA-ROP of DL-phenylalanine, which was further used by Szwarc
52
 to illustrate basic salt 
initiated NCA-ROP (Scheme 1.3). In this mechanism, the initiator acts as a base rather than 
a nucleophile abstracting a proton from the 3-N of the NCA resulting in the corresponding 
anion, which attacks the 5-CO of another NCA followed by simultaneous release of CO2, 
creating a new anion.  Monomer and solvent impurities play an important role in AMM, 
which can affect the reaction kinetics. Since the AMM proceeds via anions, propagation is 
faster than in NAM resulting in the formation of higher molecular weights polypeptides, 
whereas slower initiation than propagation in AMM leads to high polydispersities.  
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Scheme 1.3:  Activated monomer mechanism (AMM) for NCA polymerization. 
 
1.3.1.3 ‘Living/Controlled’ Polymerization of NCA 
 
The term ‘living polymers’ was first introduced by M. Swarc in connection with an anionic 
polymerization of vinyl monomers.
53
 The definition ‘Living’ combines two characteristics: 
first, the reactive end-groups of propagating chains should remain unchanged (alive) after 
100 % conversion of the monomer and second, the molecular weight distributions should 
be narrow, (PDI bellow 1.2). In 1997, Deming explored a new class of NCA-initiators, 
transition metal analogues of strong bases, to achieve first known ‘Living’ NCA 
polymerization.
42
 Since strongly basic initiators build up high molecular weight 
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polypeptides, it was hypothesized that fast chain-propagation can relatively minimize 
chain-transfer reactions. Various transition metal complexes such as amido, alkoxy, alkyl 
and carbamate complexes were screened for NCA polymerization activity and control of 
the polymerization. Zerovalent nickel and cobalt initiators [i.e., bpyNi(COD)
49
 and 
(PMe3)4Co
54
, COD = 1,5-cyclooctadiene] showed high efficiency and good control, 
reflected in synthesis of homo- and block-co-polypeptides with predictable molecular 
weights and low PDI. Both these metals react identically with NCA monomers by oxidative 
addition across anhydride bonds of NCA to from metallacyclic complexes which is general 
requirement for living NCA polymerization by transition metal initiators (Scheme 1.4). The 
presence of a metal in the final polypeptide and non-reactivity towards N-substituted NCA 
such as proline, are the major drawbacks of this technique.
55
  Recently, a transition metal 
platinum complex namely [bis(diphenylphosphino)-ethane][N-((1S,2R)-2-amido-1,2-
diphenylethyl)-4 methylbenzenesulfonamidato] platinum, has been shown to work as an 
efficient initiator  for NCA-ROP.
56
 Primary amine hydrochlorides are also capable of NCA-
ROP provided the polymerization should be conducted at elevated temperatures.
57
  Schlaad 
envisioned that the AMM pathway would be avoided at elevated temperatures as the 
concentration of the free amine species increases with the increase in rate of exchange of 
free amine and amine hydrochloride. Primary amine hydrochloride end-capped polystyrene 
was used as a macro-initiator to polymerize Z-L-lysine-NCA at temperatures between 40-
80 °C, yielding block copolymers with narrow polydispersities (PDI < 1.1) in 64-84% 
yield. However, this technique is not useful for the synthesis of multi-block co-
polypeptides owing to incomplete polymerization due to low reactivity of the active 
species, making separation of the unreacted monomer from polymer difficult.  In 2004, the 
first neat NCA polymerization initiated by primary amines was reported by Hadjichristidis 
and co-workers.
58
 Drawbacks concluded from previously reported NAM techniques led this 
group to use highly purified monomers and the application of high vacuum techniques 
(HVT) for polymerization. Using this methodology a wide variety of NCA’s could be 
polymerized to produce homo and block co-polypeptides. Various complex 
macromolecular architectures such as multi-block linear, star and star-block co-peptide 
have been synthesized by using this technique.
59
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Scheme 1.4: Transition metal mediated NCA polymerization proposed by Deming and 
co-workers.
42
 
In 2004, in an another novel approach to minimize chain termination reactions in NAM, 
Vayaboury and co-workers
60
 studied polymerization of ε-trifluoroacetyl-L-lysine NCA 
(TFA-Lys NCA) in DMF by lowering the reaction temperature and using Schlenk 
techniques under nitrogen. SEC and non-aqueous electrophoresis of reaction mixture, 
revealed an increase in the number of living chains from 22 to 99% by lowering reaction 
temperature from 20 to 0 °C. It was envisioned that at 0 °C, the activation energy barrier of 
the propagating chain is lower than the side reaction, thus dominating the reaction 
kinetically. The drawback of prolonged reaction time of this technique can be eliminated by 
11 
 
combining HVT and LTT.
61
  Applying both the techniques not only give excellent control 
over polymerization but also significantly reduce the reaction times. In 2007, Lu and 
Cheng
62
 have explored silazane derivative mediated living NCA polymerization similar to 
the group transfer polymerizations (GTP) of acrylic monomers initiated by similar 
organosilicon compounds. The block co-polypeptides such as poly(γ-benzyl-L-glutamate)-
b-poly(ε-carbobenzyloxy-L-lysine) (PBLG-b-PZLL) synthesized by sequential addition 
with this technique, showed narrow polydispersity indices and molecular weights as 
expected  with quantitative yields. In a later study, this research group showed efficiency of 
other functional group bearing N-TMS amines such as benzyl amine, propargylamine, m-
PEG200 amine as initiators for NCA polymerization. These functional groups are useful for 
further reactions such as click chemistry or ring opening metathesis polymerization.
63
 The 
rare earth metal complexes can also be employed as NCA-ROP initiators to synthesize 
homo, block, and random co-polypeptides with low polydispersities and quantitative 
conversions.
64
 Mechanistic investigation of this polymerization showed co-existence of the 
AAM and NAM paths by nucleophilic attack of a metal on the 5-CO and simultaneous 
deprotonation of the 3-NH of NCA.
65
  
 
1.3.2 Surface Grafting of polypeptides 
 
Synthetic polypeptide decorated hybrids are advantageous over the synthetic polymer 
hybrids in biocompatibility and biodegradability. As described earlier, ‘grafting to’ and 
‘grafting from’ are the most commonly used techniques to form covalently attached 
polymer brushes onto solid surfaces. Likewise, anchoring of the polypeptides onto an 
inorganic surface can be achieved by the ‘grafting to’ approach where the end-functional, 
pre-formed synthetic polypeptide synthesized by NCA-ROP is tethered covalently to an 
appropriately functional surface using coupling chemistry. The main advantage of this 
technique is the possibility of comprehensive characterization of the polypeptides prior to 
the grafting resulting in hybrids with defined composition of brushes. However, since the 
steric hindrance and diffusion of peptide chains onto the surface are limiting factors, it 
often results in non-homogeneous, low density grafting of polypeptide brushes. In 
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comparison, the ‘grafting from’ technique involves ring opening polymerization of NCA 
from initiator immobilized solid surface.  Covalently or non-covalently immobilized 
primary amines anchored to a solid support are predominantly used as an initiator.  The 
surface initiated NCA-ROP results in the formation of high density, homogeneous 
polypeptide brushes. However, control over the molecular weight and molecular weight 
distribution remains a challenge in this technique resulting from difficulties in controlling 
the initiation and propagation rates from the surface immobilized initiators.
66
 This 
drawback is offset by the high density of grafted polypeptides and the high density of 
functional groups resulting from it. This opens opportunities for rendering desired 
properties of hybrids materials useful for technological applications. Building on the 
versatility of both surface grafting techniques a wide range of organic and inorganic 
surfaces such as mesoporous and non porous silica
,67
, silicon wafers
68,69,70,71
, iron-oxide 
nanoparticles
72
, gold surfaces
73,74,75
, glass slides
76
, macro porous polymeric structures
77
, 
micro porous polymeric membranes have been decorated with synthetic polypeptides. The 
stimuli responsive properties of the surface grafted polypeptides have been used for 
applications such as molecular recognition, ion exchange and drug delivery systems.    
1.3.2.1 Polypeptide Hybrids by ‘Grafting-to’ Technique 
 
The ease of characterization of preformed polypeptide and well known thiolate-gold 
interaction resulted in an early report of disulphide end-functional poly(benzyl L-
glutamate) (PBLG) grafting onto planer gold surfaces. Samulski and co-workers
78,79
 
employed N-terminus lipoic acid modified PBLG to graft it onto the gold surface. The 
chemisorption of disulphide end-functional PBLG through strong thiolate-gold interaction 
was demonstrated by FT-IR and water contact angle measurement. The chemisorbed helical 
PBLG showed tethering to gold surface with higher grafting density when compared to 
physically adsorbed non end-functional free PBLG. In a further report, the same group 
demonstrated use of electrostatic interaction to improve the grafting of helical PBLG onto a 
charged gold surface owing to the macroscopic dipole moment of PBLG.
80
  An efficient 
tethering of PBLG helical rods through thiolate-gold interaction under the influence of an 
electrostatic field resulted in thicker films compared to their previous results. The 
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phenomenon of macroscopic dipole of helical PBLG and the strong intramolecular dipole 
interaction between the chains caused an anti-parallel alignment of the helical rods resulting 
in a double layered assembly of polypeptides on the substrate.  
By employing helicogenic (e.g. CHCL3) and non-helicogenic (e.g. DMSO) solvents to 
control the helicity of grafted PBLG, Higashi and co-workers
81 
demonstrated the reversible 
assembly of single and double-layered PBLG onto gold surface. Further demonstration of 
utilizing helical macroscopic dipole moment to graft high molecular weight polypeptides 
(Mw: 27 kDa) with higher grafting density was shown by Williams and Gupta.
82,83
 N-
lipoyl-1,3-diaminopropane was used as an initiator for NCA-ROP to obtain helical PBLG 
with a free N-terminus exhibiting a macromolecular dipole moment with opposite direction 
reported previously. These polypeptides rapidly assemble onto the gold substrate with 
surface coverage influenced by molecular weight of PBLG, solvent and assembly time.  
A different approach to graft polypeptides onto silicon surfaces was investigated by Chang 
and Frank.
69
 Functional silanes were immobilized onto planer silicon surfaces to facilitate 
the grafting of the polypeptides. Three strategies were devised: In the first approach, the 
silicon substrate was functionalized with chloroformate using 3-(trichlorosilyl) propyl 
chloroformate. A preformed PBLG was anchored to the silicon surface by using the 
interaction of terminal amino group of polypeptide and chloroformate groups present on the 
surface. In an another approach, triethoxy silane end-functional PBLG was synthesized 
utilizing 3-(aminopropyl) triethoxysilane (APTES) as an initiator for NCA-ROP and 
subsequently attached to the silicon wafer. In a third approach, the silicon surface was 
decorated with APTES and a subsequent polymerization of BLG-NCA to graft PBLG from 
the silicon surface was carried out. Although all three approaches successfully 
demonstrated PBLG grafting onto to the surface they resulted in different polypeptide film 
thicknesses and grafting densities. The first approach showed low grafting density of 
polypeptide due to PBLG dipole interaction with the substrate resulting in chains lying 
parallel to the surface, eventually causing lower grafting density. The second approach 
revealed a higher grafting density of PBLG attributed to grafting of oligomeric PBLG 
chains formed due to condensation of silanol moieties prior to surface tethering. Despite the 
success of grafting of PBLG in all three approaches, the last ‘grafting from’ approach was 
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severely hampered by intermolecular interactions. The high rate of initiation resulted in 
densely packed oligomers with β–sheet structures, making the propagating amine 
inaccessible to the solvated monomers, inhibiting further film growth. Since this report, 
significant advances have been made in the ‘grafting from’ approach making it more 
attractive technique to synthesize polypeptide hybrids.  
Similar to the planer surfaces, microporous membranes have also been investigated for the 
grafting of polypeptides to improve their properties. In an attempt to tune the separation 
properties of cellulosic membrane, Hollman and Bhattachrya
84
 grafted pH responsive 
poly(L-glutamic acid) (PHLG) onto an aldehyde prefunctionalized macroporous 
membrane. A display of conformational change from helix to coil by PHLG depending on 
the microenvironment pH was used to control the hydraulic permeability and ion selectivity 
in dilute conditions. In an another demonstration of utilizing polypeptides to diversify the 
applications of single walled carbon nanotubes (SWNTs) poly(L-lysine) surface grafting 
was employed by Li and co-workers.
85
 Primary amine groups on PLL side chain were 
coupled with carboxylic groups of oxidized SWNTs by well known carbodiimide coupling. 
The PLL functional SWNTs were then immobilized onto gold substrate followed by 
coupling of horseradish peroxide through remaining amine groups of PLL by using same 
carbodiimide coupling to construct biosensing electrode for H2O2.   
Following polypeptide grafting onto the planer surfaces, spherical surfaces such as silica 
nanoparticles were also investigated for polypeptide tethering to improve properties and 
applicability. Russo and co-workers used copper catalyzed azide-alkyne click (CuAAC) to 
tether polypeptide to nanoparticle surface.
86
 By employing propargylamine as an initiator 
for NCA-ROP, alkyl end functional poly(stearyl-L-glutamate) (PSLG) was synthesized 
followed by grafting onto azide-functionalized silica nanoparticles by azide-alkyne click 
chemistry. The surface grafted hydrophobic PSLG polypeptide improved the dispersion 
properties of silica nanoparticles in organic solvents like THF, toluene and CHCl3.   
Using a similar approach, Gupta and co-workers
87
 grafted PLL onto silica nanoparticle 
surface to investigate the gene delivery and antimicrobial applications of the hybrids. The 
CuAAC coupling of propargyl end functional poly (ε-crbobenzyloxy-L-lysine) (PZLL) 
onto azidotriethoxysilane functional silica nanoparticles resulted in core-shell silica-
15 
 
polypeptide nanoparticles. The group also successfully demonstrated grafting of 
amphiphilic block-co-polypeptide (L-lysine-b-L-leucine) from colloidal silica for 
antimicrobial applications against gram-positive and gram-negative bacteria. In an another 
demonstration of polypeptide grafting to silica nanoparticles by same research group, pH 
responsive PLGA was grafted from nano silica and its self-assembly to form 3D scaffolds 
by ice templating technique was investigated.
88
 These scaffolds possessed lamellar 
structures with fish bone type architectures (Fig.: 1.2) and showed disassembly behavior 
upon contact with water. The mechanical strength of the scaffold was increased by 
crosslinking PLGA chains with poly(ethyleneimine) (PEI).  These materials possess 
potential for applications in 3D scaffolds for tissue engineering. Like amorphous silica 
nanoparticles, mesoporous silica materials have also been grafted with PLL using similar 
CuAAC approach by Gupta and co-workers.
89
 These PLL grafted mesoporous materials 
were able to maintain their porosity after conjugation and could be useful as platform 
materials for drug delivery applications.  
 
 
Figure 1.2: Silica-PLGA composites by azide-alkyne click and their macroporous 
assembly.
88
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1.3.2.2 Polypeptide Hybrids by ‘Grafting- from’ Technique 
 
While the ‘grafting to’ technique allows the comprehensive characterization of the 
polypeptide prior to the surface grafting, its drawback is the generally low grafting 
efficiency arising from inherent steric hindrance. In comparison, ‘grafting from’ technique 
involves polymerization of NCA monomer by ROP from surface immobilized initiator to 
graft polypeptides. The later approach offers higher grafting efficiency and produces 
homogeneous polypeptide brushes. Amines or metal catalysts have predominantly been 
used as an initiator for surface initiated ring opening polymerization. Being nucleophilic, 
primary amines are excellent initiators for NCA-ROP proceeding via the normal amine 
mechanism (NAM). Under the confined conditions of a surface polymerisation it is 
possible that primary amines act as bases favouring the activated monomer mechanism 
(AMM). This can lead to non-grafted polypeptide chains in solution with high 
polydispersities. Since both the pathways might co-exist, it is essential to suppress the 
AAM to avoid free polymer formation and to ensure efficient polypeptide grafting from the 
surface. 
Most commonly, an initiator is immobilized onto the surface by forming self-assembled 
monolayers (SAM) using organosulphide/thiol and alkyl/alkoxy silane coumponds onto 
gold and silicon surfaces, respectively. However, initiators are often densely packed and 
spacing between the adjacent initiating sites is smaller than a cross-sectional area of the 
grafted polypeptides (i.e. helix).  Therefore, it was proposed that it is essential to control the 
spacing of initiating sites to offer enough space for native folding of the grafted 
polypeptide. Much work has been done on controlled spacing of initiating sites for 
example, the use of SAM with larger cross-sectional tripod structure
90
, use of mixed 
composition of initiator bearing and non bearing SAM
91,92,93
, micropattering of SAM by 
photolithography
94,95
 or microcontact printing
96
. 
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1.3.3 Surface Initiated NCA-ROP from Planar Surfaces 
 
Menzel and co-workers
68
 reported early studies on surface initiated ring opening poly-
merization (SI-ROP) of NCA-BLG from APTES functional silicon wafers. The number of 
initiating amine groups on the surface were varied by using a mixed SAM approach which 
showed a correlation with the grafted polypeptide film thickness and surface morphology. 
Typically, SAM composed of 40% initiator showed minimum surface roughness which 
only increased beyond this composition but the polypeptide film thickness remained 
unchanged. FT-IR measurements of the films showed helical confirmation of the PBLG 
chains.    
Electrochemical properties of the ultrathin polypeptide films grafted from metal surface 
were studied by Jaworek and coworkers
97
 to investigate the orientation of the helical 
strands.  Grafting of PBLG from aluminium surface under the influence of the applied 
electrical field showed inverse-piezoelectric effect indicating parallel arrangement of the 
PBLG chains. Despite the observed inverse-piezoelectric coefficient, the voltage sensitivity 
exhibited by the films was comparable to the commercial piezoelectric materials indicating 
the potential of ‘grafting from’ approach to grow piezoelectric-active films from a variety 
of electrodes and flexible substrates.   
Since surface initiated NCA-ROP in solution is observed to suffer from chain termination 
or other side reactions it often results in lower degree of polypeptide grafting and large 
proportion of monomer remains unreacted in solution. In 1996, an alternative method of 
melt surface initiated NCA-ROP was investigated by Wieringa and Schouten.
98
  In this 
study, γ-methyl-L-glutamate (MLG) NCA was deposited onto APTES functionalized 
silicon wafers using a spin coating technique. The substrates were then heated above the 
melting point of the MLG-NCA (i.e., >105 °C) to increase the mobility of the monomers 
and to allow the NCA-ROP initiation by surface bound amine groups. Although complete 
monomer conversion was achieved in 30 mins. by this method, only 20% of the monomer 
was polymerized from the surface since NCA monomer can undergo thermal 
polymerization at elevated temperatures. In spite of low polypeptide grafting, the surface 
grafted PMLG brushes were shown to adopt purely α-helical structures while the non 
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grafted free polypeptides showed both α-helical and β-sheet confirmations. Another solvent 
free approach for grafting of polypeptides from amine functional planer surfaces was 
investigated by Frank and Chang
70
 in 1997. PBLG chains were grafted from APTES 
functional silicon wafers through the vapour deposition polymerization. In VDP the 
vacuum reaction conditions (0.02-0.04 Torr) allow the NCA vaporization to occur at much 
lower temperatures than in the melt polymerisation and the monomers remains mobile in 
the gaseous phase until they condense onto the substrate. This method is advantageous over 
melt polymerization for reproducibility and its ease to vary local monomer concentration to 
obtain polypeptide films of tuneable thickness. Wang and Chang
99
 introduced further 
improvements to the VDP method. By redesigning the reaction chamber and optimizing the 
reaction conditions the versatility and robustness of the improved VDP was demonstrated 
by surface grafting of homo and block co-polypeptide films of PZLL, PMLG, PPA and 
poly(-benzyl-L-aspartate) (PBLA). 
A better controllable method of grafting polypeptides in solution from solid surfaces such 
as silicon and quartz wafers was studied by Schouten and co-workers.
100,101,102
 SI-ROP of 
NCA-BLG and NCA-MLG was carried out from APTES functionalized silicon wafers and 
quartz slides in anhydrous N, N-dimethylformamide (DMF) at 40 °C.  Most of the 
polypeptide growth occurred in the first 5 h of the reaction and polypeptide film thickness 
showed a pronounced dependence on monomer concentration in solution. The surface 
grafted polypeptides showed pure rigid α-helical confirmations with perpendicular 
orientation to the surface. The effect of monomer size onto helix orientation was studied by 
comparing helix-surface tilt angles (θ).  PMLG with smaller methyl side group displayed a 
more upright orientation with higher tilt angle compare to PBLG (benzyl side group) 
attributed to higher grafting density combined with steric hindrance and unfavourable polar 
interactions. The authors also reported the first time synthesis of surface grafted block co-
polypeptide films.
102
  Due to the shorter reaction times, the chain termination and the 
formation of free polypeptides in solution are least favourable ensuring reactive amino end 
groups intact for further polypeptide growth. A diblock co-polypeptide composed of PBLG 
as first block and a second block of PMLG were synthesized from APTES functional 
silicon wafers. Polymerization of the BLG-NCA was carried out from the surface for short 
period of time (2 h). After removal of the unreacted monomer, the grafted PBLG chains 
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were used as macro-initiators for subsequent polymerization of MLG-NCA. Using X-ray 
photoelectron spectroscopy (XPS) it was found that maximum grafting density for PBLG 
was not achieved within an hour of reaction and polymerization of the second monomer 
NCA-MLG at this stage leads to formation of PMLG helices in between the preformed 
PBLG brushes. Following the studies of helical orientation on planer surfaces, Schouten 
and co-workers
103
 investigated the reversible inversion of helical screw sense of surface 
grafted polypeptide by means of external stimuli. SI-ROP of β-phenethyl-L-aspartate N-
carboxyanhydride from APTES functional quartz surface yields poly(β-phenethyl-L-
aspartate) (PPELA) films with right handed helical confirmation. Inversion of the helical 
screw of grafted chains to left-handed π-helical conformation takes place upon annealing of 
the films at 150 °C for 30 min. The inversion is completely stable under any conditions of 
further temperature changes. Reversal of the helical screw inversion to the original only 
takes place upon immersion of the annealed films into helicogenic solvent (e.g. CHCl3). 
The inversion of the helical orientation is repeatable over many cycles of annealing and 
solvent treatment. The authors also devised a chemical crosslinking procedure to preserve 
the desired helical conformation.
104
 
The effect of macrodipole moment of pre-grafted polypeptide onto the rate of 
polymerization of growing polypeptide chain was studied by Higashi and co-workers.
105
 
Modified PBLG with disulphide moieties at C-terminus (PBLG-C-SS) and N-terminus 
(PBLG-N-SS) were synthesized and grafted onto the gold surfaces. The resulting PBLG 
films showed opposite macrodipole moments. The polypeptide uncovered surface area of 
the films was subsequently amine functionalized using a mixed SAM approach. ROP of 
BLG-NCA from the initiator immobilized gold surface experienced the influence of 
direction of macrodipole moment of the pre-adsorbed PBLG chains. The rate of NCA-ROP 
from the gold surface in the presence of the pre-adsorbed PBLG-N-SS increased by ten 
folds compared to in the absence of the pre-adsorbed polypeptide. The authors attributed 
the increase in rate of polymerization to the macrodipole moment of PBLG-N-SS which is 
anti-parallel to the direction of growing PBLG chain favouring the formation of PBLG with 
higher degree of polymerization (DP:95). On the other hand, the PBLG-C-SS showed a 
parallel macromolecular dipole moment to the direction of growing polypeptide chain 
resulting in grafting of PBLG with lower degree of polymerization (DP:15). 
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Recently, in an attempt to create non-fouling polypeptide films onto planer surfaces, Klok 
and co-workers
106
 polymerized oligo(ethyleneglycol) modified L-lysine from APTES 
functional silicon, quartz and glass surfaces. The success of polymerization was confirmed 
by XPS analysis and circular dichroism (CD) measurements which confirmed the α-helical 
confirmation of the grafted polypeptides. When investigated for the nonspecific adsorption 
of the fluorescently labelled proteins such as bovine serum albumin (BSA) and fibrinogen 
(FBG), the non-fouling polypeptide coated substrates exhibited significant reduction in 
fluorescence intensity compared to non-coated surfaces.  
 
1.3.4 Surface initiated NCA-ROP from non-planar surfaces 
 
The earliest report of polypeptide grafting from colloidal silica particles was done by 
Harmann and co-workers
107
 in 1974. The ROP of L-alanine NCA (Ala-NCA) and L-leucine 
NCA (Leu-NCA) was carried out from aminophenyl functionalized silica particles at 15 °C 
in dioxane. The polypeptides thus formed by ROP could not be separated from silica 
particles by extraction technique, which led to the conclusion of the covalent attachment of 
the polypeptides onto the silica particles.  Colloidal silica polypeptide hybrids with 20 to 
85% unextractable polypeptide content were obtained by this method. Similarly, carbon 
black surfaces functionalized with amino, methyl amino and dimethyl amino moieties were 
investigated for NCA-ROP of MLG-NCA by Sone and co-workers.
108
 As a result of better 
initiation, primary amine functionalized carbon black particles presented higher grafting 
efficiencies compared to other amines. Despite incomplete studies of uniformity of the 
polypeptide grafting due to limitation of synthetic tools and characterization techniques, the 
report conclusively proved the use of ‘grafting from’ technique to obtain surface-tethered 
polypeptides. 
In 1999, Russo and co-workers reported synthesis of organophilic silica colloids by surface 
initiated ring opening polymerization.
67
  Homopolypeptide decorated silica nanoparticles 
were synthesized by polymerization of BLG-NCA from APTES decorated Stöber silica 
nanoparticles (~100 nm) (Fig.: 1.3). In this report, the authors could demonstrate surface 
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initiation of NCA-ROP but were not able to quantitatively graft polypeptides onto the 
nanoparticle surface. Observed polypeptide shell thickness was much smaller than the 
thickness calculated by geometrical considerations. This was attributed to the chain 
termination reactions on the surface and free initiator induced solution polymerization to 
form free polymer. Covalent attachment of polypeptides to the surface was proven by 
characterization with techniques like FT-IR, TGA, SEM, DLS after repeated washings of 
nanoparticles with DMF followed by centrifugation to remove unbound polypeptide. When 
analyzed by thermo gravimetric analysis, polypeptide shell could account for 20% of the 
total composite mass. The same research group continued their work by exploring 
polypeptide silica composites and further studied silica-poly(ε-carbobenzyloxy-L-lysine) 
(PCBL) composites.
109
 Unlike the first reported PBLG-silica composites, PCBL grafted 
core-shell particles showed distinct α-helical confirmation of the homopolypeptides. The 
chiral polypeptide decorated silica particles with appropriate size showed a spontaneous 
ability to from crystals, which showed the similar optical properties as achiral polymer 
decorated particles. 
 
Figure: 1.3: Production of Silica-PolypeptideColloidal Composite Particles.
67
 
In 2010, in an elaborated study of synthetic polypeptide-silica hybrids synthesized by 
immobilized initiator induced NCA polymerization, the same research group attempted to 
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show ‘livingness’ of the polymerization technique by sequential re-addition of monomers 
resulting in an additional shell growth (Fig.: 1.4).
110
 CBL-NCA was polymerized from 
APTES decorated silica nanoparticle surface using DMF as a solvent at room temperature. 
After complete polymerization of initial monomer, a new batch of monomer was added to 
the polymerization solution. When analyzed by DLS for hydrodynamic radii, nanoparticles 
showed relative increase in the shell thickness in accordance with the monomer addition. 
To avoid previously seen chain termination reaction attributed to steric crowding of 
polypeptides, the same researchers have used amine functional and amine non-functional 
(reactive and passive) silanes to decorate nanoparticle surface. Due to passivation of the 
particle surface with non-functional silane, the grafting density of the synthetic 
polypeptides onto the surface dramatically reduced and the composite particles revealed 
‘spiky’ appearance when analyzed by TEM (Fig.: 1.4). Despite the good control over the 
polymerization, the authors could not control the free polymer formation. This led to a 
discrepancy of mass conversion of NCA and actually tethered polypeptide. 
 
Figure 1.4: Production of Si-PCBL core-shell particles by sequential addition of 
monomer.
110
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SI-RIOP to graft polypeptides has also been employed from ordered mesoporous silica 
(OMS) to improve properties of OMS for desired applications. SI-ROP of ZLL-NCA and 
Ala-NCA was carried out from aminopropyltrimethoxysilane (APTMS) functionalized 
mesoporous silica nanoparticles by Lunn and Shantz.
111
 The porosity of resultant 
polypeptide-OMS composites was found to be lower than polypeptides nongrafted OMS 
attributed to high grafting density of polypeptide brushes onto the surface. Moreover, the 
grafting density of the polypeptide could be varied as a function of initiator density, pore 
size, pore topology and type of monomer.  
Other than inorganic surfaces, recently Heise and co-workers
77
 employed the SI-ROP to 
macroporous polymeric monolith to demonstrate the grafting of polypeptide chains to tailor 
the bioconjugation properties of the monoliths (Fig.: 1.5). The porous polymers 
synthesized within high internal phase emulsion (polyHIPE) are an interesting class of 
materials with high surface to volume ratio making them useful for the applications in 
tissue engineering, 3D cell culture, filtration/separation techniques, etc. The authors 
synthesized amine functional polyHIPE by polymerizing styrene, divinylbenzene and 4 
vinylbenzylamine in water at 70 
o
C with the help of surfactant Span-80. The primary amine 
moieties present on the surface of resultant polyHIPE-NH2 were used as initiating sites for 
SI-ROP of BLG-NCA and ZLL-NCA to form high density brushes of PBLG and PZLL 
respectively. Subsequent deprotection of the side chain functionalities of the grafted 
polypeptide brushes resulted in high density functional group coatings rendering pH 
responsive properties to polyHIPE. Furthermore, authors employed deprotected 
polypeptide coatings (eg. –COOH functional PLGA) for the bioconjugation of enhanced 
green fluorescent protein (eGFP) and fluorescein isothiocyanate (FITC). 
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Figure 1.5: Synthetic pathways to polypeptide-grafted polyHIPE and subsequent 
bioconjugation.
77
 
 
Multiwalled carbon nanotubes (MWNT’s) have also been decorated with polypeptides 
using surface-initiated NCA-ROP. Hua and co-workers
112
 synthesized amine functional 
MWNT’s by reacting carboxyl functional oxidised MWNT’s with excess 1,6 
diaminohexane, followed by surface-initiated ROP of NCA-ZLL from amine moieties. The 
deprotection of resultant PZLL grafted MWNT’s resulted in water dispersible PLL-grafted 
MWNT’s. This approach can address the problem of processability of carbon nanotubes, 
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which are interesting materials for technological applications such as molecular wires, 
sensors, probes, and biological electronic devices. 
Magnetic nano and micro particles possesses unique physico-chemical properties like 
superparamagnetism, high saturation field, high field irreversibility and high surface to 
volume ratio could find applications in biomedical technology. In recent years, attempts 
have been made to enhance properties and to impart unique functionalities to these 
nanomaterials by employing surface-initiated NCA-ROP. Yang and co-workers
113
 prepared 
magnetic-silica polypeptide hybrids by polymerizing NCA-BLG from nanoparticle surface. 
Firstly, Magnetite (Fe3O4) particles prepared by solvothermal process were encapsulated in 
silica shell by sol-gel reaction followed by silanization with APTES to impart amine 
functionality to the nanoparticle surface. These primary amine moieties were used as an 
initiator to polymerize NCA-BLG from the particle surface to afford the magnetic-silica 
polypeptide hybrids. The hybrids showed enhanced colloidal dispersion stability (more than 
3 days), though magnetic separation of the colloids could be achieved (t= 10 s) the presence 
of the external magnetic field.   
Silica coatings onto magnetic particles might reduce the magnetic properties of the particles 
limiting their use in certain applications. Fernandez-Garcia and co-workers
72
 designed a 
new strategy for functionalization of magnetic nanoparticles by employing self-
polymerization of dopamine onto nanoparticle surface to introduce amine functionalities. 
These amine groups were then used for surface initiated polymerization of NCA-BLG to 
graft PBLG chains onto particle surface. Followed by the deprotection of the PBLG chains, 
the resultant pH responsive nanoparticles were conjugated to the model drug procaine to 
investigate the applications of the nanoparticles for magnetic resonance imaging (MRI) and 
drug delivery. Following the similar approach, magnetic-peptide-metal nanohybrids also 
been prepared.
114
 To the PBLG grafted magnetic nanoparticles, catechol functionality was 
imparted to the polypeptide shell by aminolysis with dopamine. Gold nanoparticles were 
then formed in polypeptide shell in situ by allowing gold ions to interact with the catechol 
functionalities followed by reduction with sodium borohydride. The catalytic activity of the 
gold-decorated magnetic-polypeptide hybrids to reduce 4-nitrophenolate ions to 4-
aminophenol was investigated. The hybrids displayed high catalytic efficiencies 
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(conversions up to 95% in 25 min), the ability of magnetic separation and the nanoparticles 
could be reused over 8 times without significant loss of catalytic activity. 
    
1.4 Conclusion and Scope of Thesis 
 
With the advancements of surface grafting techniques to synthesize nanoscale polypeptide 
hybrids, an exciting platform has been opened to design and synthesize the new class of 
hybrid biomaterials. A wide range of functionality, capability of undergoing 
conformational changes and phase transition in response to the chemical and physical 
changes of the microenvironment are strong arguments for candidature of polypeptide-
based hybrids for biomedical applications. As summarized here, researchers have taken the 
advantages of these aspects and tried to develop a range of hybrids with desired properties. 
While in the early stage focus has mostly been on surface grafting of polypeptide films and 
its characterization, recently efforts have been made to answer the challenges associated 
with surface initiated NCA-ROP such as suppression of side reactions and formation of 
non-grafted materials. The aim of the presented research work is to design a facile synthetic 
strategy to graft polypeptides from nanoparticle surfaces.  Minimal formation of the free 
polymer could be the key factor to graft dense polypeptide shell onto inorganic nanoparticle 
surface. This could be achieved by careful decoration of nanoparticle surfaces with primary 
amine initiators and dry, inert reaction conditions. First platform of the research will be to 
develop SI-NCA-ROP technique from silica nanoparticle surface. NCAs of various amino 
acids will be polymerized by SI-ROP to check the versatility of the technique. In later 
platform, new materials with sophisticated architecture and complex properties highly 
desired for applications like imaging, theranostics will be developed by employing the 
developed polymerization technique from iron oxide nanoparticle surfaces.    
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Chapter 2 
 
Polypeptide Core-Shell Silica Nanoparticles with 
High Grafting Density by N-Carboxyanhydride 
Ring Opening Polymerization 
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Abstract 
 
Silica nanoparticles were furnished with a functional polypeptide shell to create a pH-
responsive inorganic-organic hybrid material. Free amine groups present on silica 
nanoparticles initiated the N-carboxyanhydride (NCA) polymerization of particular amino 
acid NCAs directly onto the inorganic support, offering a convenient method to 
functionalize silica core nanoparticles with a uniformly dense polypeptide shell. Poly(γ-
benzyl-L-glutamate) (PBLG), poly(ε-carbobenzyoxy-l-lysine) (ε-CBZ-PLL), and S-tert-
butyl protected polycysteine (tB-PLC) were grafted from the silica core both independently 
as homopolypeptides, and simultaneously to form a copolypeptide shell, highlighting the 
versatility that the grafting mechanism possesses. The grafting of PBLG was investigated in 
detail at 0 °C and 20 °C to determine any differences in the size and uniformity of the 
polypeptide shell formed. Dynamic light scattering (DLS) analysis revealed a correlation 
between the thickness of the uniform organic shell and the amount of amino acid in the 
monomer feed, with higher linearity at the lower polymerization temperature. Size 
Exclusion Chromatography (SEC) analyses of degrafted PBLG confirmed the DLS results. 
A high grafting density of around 0.4 PBLG chains per nm
2
 was calculated highlighting the 
control afforded in this approach to polypeptide grafting. Subsequent deprotection of the 
PBLG homopolypeptide shell afforded pH-sensitive poly(glutamic acid) (PGA) coupled 
silica nanoparticles. The selective release of a model rhodamine B dye was demonstrated to 
emphasize the potential that these hybrid nanomaterials have for the on-demand release of 
payload molecules in response to a targeted pH trigger 
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2.1 Introduction  
 
The organic functionalization of inorganic materials offers potential to develop novel 
inorganic-organic hybrid materials capable of displaying a range of desired behaviors.
1
 In 
particular, the use of nanostructured silica is of special interest as it permits a wide range of 
functionality arising from its unique optical, electrical and physical properties. Tailoring the 
material surface properties, through its designed chemical modification, has been 
demonstrated in a variety of applications ranging from simple fillers to highly active 
components in biomedical devices including anti-microbial agents,
2,3
 biodiagnostic 
devices
4
 and drug delivery mechanisms.
5,6
 Advanced biomedical applications necessitate 
that the surface groups must provide several key functions to enhance the materials 
effectiveness. Surface conjugation with markers or biomolecules, enhanced 
biocompatibility and increasingly stimuli responsiveness are important factors that may be 
engineered into the design of the material to improve its performance. Stimuli-responsive 
materials possess the capability to change their macroscopic properties upon changes in 
targeted external stimuli such as temperature,
7
 light,
8
 ionic concentration,
9
 electric/magnetic 
field,
10,11
 and enzyme selectivity.
12,13
 Recent developments concerning this category of 
materials have been vast with suggested applications found in fields including the targeted 
release of therapeutic agents,
14
 biodiagnostics,
15
 and chronic wound healing.
16
 In addition, 
pH-responsive materials have been devised and developed with the aim of manipulating 
differing pH levels that exist within distinct organs and disease states within the human 
body. Such differences dictate that polymeric materials possessing the capability to respond 
to different environmental pH levels are suitable candidates as drug carriers in medicinal 
applications. 
Polymer conjugation to the silica nanoparticle surface by initiating polymerization from an 
immobilized initiator (grafting from) is a promising way to generate a high grafting density 
of a functional organic shell onto an inorganic surface.
17,18
 In particular, radical 
polymerization methods have been employed for the surface modification of silica 
nanoparticles in this manner including conventional radical polymerization, atom transfer 
radical polymerization (ATRP), reversible addition-fragmentation chain transfer 
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polymerization (RAFT), and nitroxide-mediated Polymerization (NMP). The main 
advantages of these techniques include excellent control over the grafting thickness and a 
large choice of readily available monomers, which allows the introduction of various 
functional groups to the silica nanoparticle surface. A drawback is that radical 
polymerization is limited to vinyl polymers, while in many applications there is a need for 
biocompatibility and sometimes biodegradability. An alternative method is the use of 
synthetic polypeptides, which offer biocompatibility in conjunction with a degree of 
functional diversity. The functionality offered by the polypeptide can be readily tuned 
dependent on the particular amino acid groups selected from the pool of natural and non-
natural amino acids available.  
Our interest is in the synthesis of functional, stimuli-responsive, polypeptide nanoparticles 
for sensor and biomedical applications. We reported poly(γ-benzyl-L-glutamate) 
(PBLG)/polystyrene core-shell nanoparticles obtained by the combination of controlled 
radical and NCA polymerization.
19,20
 Recently “grafting to” approaches of alkyne terminal 
synthetic polypeptides onto azide functional silica nanoparticles by employing copper 
catalyzed ‘click’ chemistry were reported.21,22 The disadvantage of this approach is the 
usually lower grafting density due to increasing steric hindrance with increasing grafting 
density. This can be circumvented by the “grafting from” approach, which has been 
extensively utilized in the synthesis of polypeptide brushes on planar silicon wafers by ring 
opening polymerization of NCA in solution,
23-29
 melt
30
 and by vapor deposition 
polymerization.
31-38
 Research by the group of Russo demonstrated that the “grafting from” 
approach of PBLG can also successfully be applied from silica nanoparticles.
39
 Further 
work demonstrated the grafting of poly(ε-carbobenzyoxy-l-lysine) (ε-CBZ-PLL) from the 
silica nanoparticle surface with special emphasis on controlling the polypeptide shell 
thickness by sequential monomer addition.
40
 However, the grafting did not appear to be 
completely uniform in all cases and only very low mass increases (the grafting efficiency 
was calculated as 1.85% after four grafting steps) were observed despite the excessive 
addition of NCA monomer. This was stated to be either due to the monomer not reacting, 
or the formation of unbound polymer. 
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In order to expand the range of stimuli-responsive polypeptide decorated nanoparticles, we 
have investigated the direct grafting of various polypeptide and copolypeptide shells from 
silica nanoparticles by N-carboxyanhydride (NCA) polymerization at both 0 °C and 20 °C 
to ascertain optimal grafting conditions. Free amine groups present on silica nanoparticles 
act to initiate the polymerization of NCAs directly onto the silica support, offering a 
convenient method to functionalize inorganic silica core nanoparticles with a dense 
polypeptide shell (Scheme 2.1). A clear aim of this work is to produce uniform polypeptide 
shells whilst eliminating the generation of non grafted polypeptide, thus enabling the 
efficient generation of high molecular weight polypeptides grafted from silica nanoparticles 
surfaces. The hydrodynamic diameters of the polypeptide-silica conjugates were measured 
to determine a correlation between the dimensions of the functionalized nanoparticles 
formed and the amount of NCA monomer present in the monomer feed, and to confirm the 
lack of ungrafted polypeptide associated to the completed product. The molecular weight 
and polydispersity of the grafted chains could be determined by GPC following the etching 
of the silica core to provide a comprehensive analysis of the polymerization whilst 
demonstrating the extensive control that the polymerization methodology affords. Finally, 
we demonstrate the ability to use these nanoparticles as carrier vehicles in a pH-responsive 
release application.  
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Scheme 2.1: Schematic representation of amino functionalization of silica nanoparticles 
(Si) with 3-aminopropyltrimethoxysilane (APTS) and the facile grafting of a polypeptide 
from the silica nanoparticle surface by the ring opening polymerization of an amino acid 
NCA in DMF. R: CH2CH2COOBz (PBLG); R: CH2S-StBu (tBPLC) and R: 
CH2CH2CH2CH2NHCOOBz (e-CBZ-PLL). 
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2.2 Results and Discussion 
 
2.2.1 Synthesis of peptide grafted silica nanoparticles 
 
The synthetic strategy for the conjugation of peptides to silica nanoparticle surfaces is 
shown in Scheme 2.1. Silica nanoparticles (~120 nm diameter) were initially modified with 
APTS at room temperature to generate primary amine groups on the nanoparticle surface.
41
 
The success of this modification was verified by elemental analysis, which revealed that the 
silica nanoparticles contained 0.72 % nitrogen content by mass while no nitrogen was 
detected on the unmodified nanoparticles. DLS measurements in ethanol revealed an 
increase in hydrodynamic diameter from 122 nm to 136 nm, indicating multilayer 
formation of APTS on the silica nanoparticle surface.
42
 This means that a large fraction of 
the amino groups are not exposed at the particle surface and cannot take part in the 
initiation of the NCA. Consequently, a molar monomer to initiator ratio cannot be 
calculated and instead a constant NCA to silica particle mass ratio was used in the 
polymerizations. The primary amine groups of covalently attached APTS exposed on the 
nanoparticle surface were then utilized to initiate the ring opening polymerization of the 
NCA of a desired amino acid, resulting in polypeptide grafting from the nanoparticle 
surface. In order to verify the versatility of the grafting approach, the attachment of three 
amino acid NCAs, γ-benzyl-L-glutamate (BLG), ε-carbobenzyoxy-l-lysine (ZLL), and S-
tert-butyl protected polycysteine (tBLC), was carried out at 0 °C both independently to give 
each homopolymer, and in the case of BLG and tBLC simultaneously to form the random 
copolymer. These amino acids were selected because following their deprotection useful 
functional groups (thiol: cysteine, amine: lysine and carboxylic acid: glutamic acid) are 
introduced into the polypeptide that may be used for subsequent chemical modification, 
stimuli responsiveness and (bio)conjugation. It has been widely reported within the 
literature that carrying out NCA polymerizations at 0 °C suppresses both unfavorable side 
reactions and premature chain termination.
43-45
 Consequently, a study was undertaken 
whereby the NCA of BLG was additionally polymerized at 20 °C to determine any 
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disparity in polypeptide uniformity and molecular weight between the product formed at 
this temperature and the product formed at 0 °C. 
Due to the good solubility of NCA-BLG and NCA-ZLL in DMF the grafting reactions of 
these monomers were carried out in this solvent. During the course of the polymerization, 
the DMF solution remained homogenous and the silica nanoparticles were recovered by 
precipitation in diethyl ether and centrifugation. Initially, unbound polypeptide formed 
during the grafting process as reported by Russo et al.
39,40
 The presence of such material is 
detrimental to the system proposed; the polypeptide shell thickness cannot be accurately 
determined and the effectiveness of the hybrid materials as vehicles for the controlled 
release of payload molecules is diminished. We speculate that it may be caused by traces 
free APTS initiating the NCA in solution. Consequently, exhaustive washing of the silica 
nanoparticles in THF prior to the NCA polymerization resulted in the absence of any free 
polymer as analyzed by TGA. After washing with THF and drying under vacuum the 
success of the grafting reaction was investigated by NMR, FTIR, TGA and TEM. Figure 
2.1 b shows an example of an ATR-FTIR spectrum of PBLG grafted silica nanoparticles 
(NP-g-PBLG) and the NCA-BLG monomer (Figure 2.1 a). The latter reveals strong peaks 
at 1772 cm
-1
 and 1880 cm
-1
 that are attributed to the C=O groups of the anhydride. A third 
characteristically strong peak at 3331 cm
-1
 is attributed to the secondary amine present in 
the anhydride ring. These typical NCA peaks were not present in the spectrum 
corresponding to silica nanoparticles after the grafting. Instead, the IR spectra of the 
polypeptide-conjugated silica nanoparticles reveals peaks characteristic of PBLG, i.e. the 
peptide carbonyl group of amide I and amide II at 1652 cm
-1
 and 1547 cm
-1
 (Figure 2.1 b). 
The position of these peaks also suggests that PBLG adopts an α-helical conformation in 
the dry state.
46
 Moreover, the broad peak at 3291 cm
-1
 is due to N-H stretching of amide 
linkage, the carbonyl group within the benzyl ester can be assigned at 1732 cm
-1
, and the 
very broad peak at 1040 cm
-1
 is due to the Si-O-Si bonds present within silica nano-
particles.  
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Figure 2.1: FTIR spectra of (a) NCA-BLG (b) NP-g-PBLG (c) Benzyl deprotected NP-g-
PGA. 
 
A series of control experiments were then carried out specifically to further verify covalent 
polypeptide grafting from the silica nanoparticles. Most significant in that respect was an 
experiment in which amine functional nanoparticles were mixed with free PBLG. 
Following this, the material was washed several times with THF and recovered by 
centrifugation, i.e. treated in an identical multi-step washing process. No PBLG IR signals 
were detected signifying the lack of any unbound polypeptide in the system. The same 
negative result was obtained when the grafting process was carried out with silica 
nanoparticles that lack amino groups. These control experiments provide strong evidence 
that the characteristic IR and NMR signals indeed stem from PBLG grafted to the silica 
nanoparticles.  
The hydrodynamic diameters of PBLG-conjugated nanoparticles created in reactions 
carried out at 0 °C and 20 °C were measured to determine any diversity in the dimensions 
or polydispersities of the products created (Figure 2.2). The results exhibit the control over 
size of the PBLG-silica nanoparticles dictated by the ratio of NCA monomer to silica 
nanoparticles; a higher ratio results in larger functionalized nanoparticles as expected. 
When the reactions were carried out at 0 °C a significant increase in hydrodynamic radii 
from 172 to 236 nm (PDI: 0.04-0.09) was observed when ratio was increased from 1 to 3, 
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respectively. At 20 °C a similar increase in hydrodynamic size from 150 nm to 210 nm 
(PDI: 0.04-0.13) was measured by DLS when ratio was raised from 0.5 to 2. In particular, 
the data corresponding to the 0 °C reactions converges towards linearity, suggesting better 
control over polypeptide grafting offered by this reaction condition in agreement with 
results obtained in solution. The DLS observations are in agreement with results obtained 
from thermo-gravimetric analysis (TGA) where an increasing polymer weight loss was  
measured with increasing NCA to nanoparticles ratio (Figure 2.3). 
 
 
Figure 2.2: Size and polydispersity index (PDI) obtained by DLS of PBLG grafted silica 
nanoparticles for polymerization reactions carried out at 0 (top) and 20 °C (bottom). 
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Figure 2.3: TGA Analysis of (a) Si NP-OH (b) Si NP-NH2 (c) Si NP-g-PBLG (mass ratio 
1:1), (d) Si NP-g-PBLG (mass ratio 1:2), (e) Si NP-g-PBLG (mass ratio 1:3). All 
polymerization carried out at 0 °C. 
 
In a preliminary attempt to gain information regarding the molecular weight of the grafted 
PBLG achieved at both 0 °C and 20 °C, hydrofluoric acid was used to etch the silica core 
from the PBLG shell to enable the analysis of the polypeptide by GPC (Table  2.1). In both 
cases extensive control over the polymerizations were afforded with the molecular weights 
of the polypeptides generated increasing proportionally with the increase in BLG NCA 
within the monomer feed. Polypeptides possessing enhanced molecular weights were 
generated when the reactions were done at 20 °C.  
 
 
a 
b 
d 
c 
e 
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Table 2.1: GPC molecular weights and PDIs of PBLG degrafted from selected silica 
nanoparticles. 
Sample 
NCA-BLG/Si 
NP  
Mass Ratio 
Reaction 
Temperature (°C) 
Mn 
(g/mol) 
PDI 
Si NP-
PBLG 
1 
1:1 0 7700 1.4 
Si NP-
PBLG 
2  
2:1 0 16100 1.4 
Si NP-
PBLG 
3  
3:1 0 20700 1.4 
Si NP-
PBLG 
4  
1:1 20 8700 1.4 
Si NP-
PBLG 
5  
1.5:1 20 15000 1.2 
Si NP-
PBLG 
6  
2:1 20 20100 1.3 
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Molecular weight measurements of degrafted PBLG from the silica nanoparticles surface 
along with TGA results of these hybrids enable us to determine the grafting density. The 
grafting density of APTS initiator GAPTS onto silica nanoparticles was found to be 2.4 APTS 
per nm
2
. Polymer grafting density GPBLG of PBLG grafted onto silica nanoparticles at 0 °C 
with varying molecular weights was found to be in the range of 0.4 polymer chains per 
nm
2
. Considering that the radius of a PBLG helical rod was reported to vary within the 
range of 0.8-1.3 nm depending on the conformation of the side chain (cross-section area: 
2.0-5.8 nm
2
) this suggests a high grafting density under the conditions applied.
47-49
 To our 
knowledge this is the first time that GPC data and grafting density concerning silica 
nanoparticle-grafted PBLG has been disclosed in the academic literature. 
To demonstrate the versatility that the system possesses to graft a range of 
homopolypeptides to silica nanoparticles, tBLC was chosen as a second amino acid to form 
a polypeptide conjugated to silica nanoparticles owing to its potential to utilize the cysteine 
thiol for further reactions in future studies.
51
 In an analogous fashion to that demonstrated 
for the conjugation of PBLG to the silica nanoparticles, the NCA of tBLC was formed and 
nanoparticle initiated polymerization was done to yield the desired silica NP-g-PtBLC 
product. Due to the limited solubility of the tBLC peptide in a wide range of solvents, 
several experiments were carried out which resulted in chloroform (CHCl3) being selected 
for use in the grafting of tBLC to the nanoparticle surface. Characterization of silica NP-g-
PtBLC nanoparticles by ATR-FTIR showed the presence of two peptide conformations, β-
sheet (amide I C=O stretching absorbs at 1633 cm
-1
) and random coil (amide I absorbs at 
1657 cm
-1
). Due to the lower solubility of the cysteine homopolypeptide, a lower weight 
ratio (100 mg silica NP-NH2:100 mg NCA-tBLC) of NCA-tBLC to amine functionalized 
silica was employed and resulted in the grafting of a cysteine homopeptide shell with lower 
thickness compared to that observed for the polypeptide shell of NP-g-PBLG as analyzed 
by TEM.   
ZLL was chosen as the final amino acid to graft from the silica nanoparticle surface to 
afford silica NP-g-PZLL following the nanoparticle-initiated polymerization. The extent of 
peptide grafting was determined by TGA revealing a hybrid material consisting of 70% 
inorganic core surrounded by 30% organic shell by mass. Deprotection of the CBZ 
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protecting group further reduces the organic part of the hybrid material, leaving a final 
product with a mass composition of 80% silica core surrounded by 20% PLL shell. Upon 
deprotection cationic polylysine offers a pH-responsive shell to the particles that may be 
employed further for biotinylation or anti-microbial applications. Characterization of the 
particles by ATR-FTIR revealed the amide I and amide II bands at 1651 cm
-1 
and 1535 cm
-1
 
in addition to a peak at 1698 cm
-1
 representative of the C=O present in the carbobenzyloxy 
protecting group (Figure 2.4 a). Following the deprotection of the lysine R group this peak 
is lost, signifying the generation of free amine groups (Figure 2.4 b). These deprotected 
lysine silica hybrids (NP-g-PLL) are highly hydrophilic and readily disperse in water to 
form homogeneous clear suspensions as the side chain amino group residue present in 
lysine has a pKa of 10.53. The hydrodynamic radii of PLL grafted silica nanoparticles 
particles were found to be 182 nm measured by DLS in pH4 aqueous solution.       
 
Figure 2.4: FTIR spectra of (a) NP-g-PZLL (b) NP-g-PLL (after deprotection). 
 
To further demonstrate the adaptability of the polymerization technique, core-shell 
nanoparticles were then produced consisting of a silica nanoparticle core surrounded by a 
copolypeptide poly(BLG-co-tBLC) shell. The copolypeptide shell was grafted to the silica 
core in the molar ratio of 80:20 (BLG:tBLC). As the molar ratio of BLG was significantly 
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1539
1651
3264
cm
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greater than that of tBLC, the silica conjugated copolypeptide displayed a similar IR 
absorption spectrum to that of PBLG grafted silica particles. While difficult to quantify, 
1
H-
NMR analysis suggests the presence of both amino acids in the particle shell due to the 
appearance of benzyl ester (7.19 ppm and 4.96 ppm) and t-butyl peaks (1.18 ppm) protons.  
TEM was used to image the peptide silica hybrid particles and revealed distinct core-shell 
morphologies. An inorganic silica core appears darker than the grafted organic peptide shell 
due to the difference in density. Comparison of TEM images in Figure 2.5 a, b, c of 
peptide grafted hybrid silica nanoparticles with image (d) of amino functionalized bare 
particles confirms the successful ring opening polymerization of NCA by the amino 
functional group present on the APTS functionalized silica particles. The average particle 
size as estimated by TEM measurements of these peptide grafted silica hybrid particles was 
found to be in the range of 150-170 nm with a shell thickness of 10-20 nm. This concisely 
agrees with DLS measurements, which showed a hydrodynamic radius of 170 nm. The 
nanohybrid materials also showed a perfect core-shell structure, highlighting the uniform 
grafting of the copolypeptide from the silica nanoparticle surface.  
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Figure 2.5: TEM images of peptide grafted silica nano particles (a) NP-g-PBLG (b) 
NP-g-PtBLC (c) NP-g-PLG (d) NP-OH. 
 
The conversion of the silica nanoparticle-conjugated PBLG polypeptides to pH-responsive 
grafted PGA polypeptides was achieved by the deprotection of the PBLG benzyl ester 
groups directly on the silica nanoparticles by HBr/AcOH treatment. The progress of this 
reaction was monitored by FTIR spectroscopy, which showed the disappearance of the 
ester peak at 1732 cm
-1
 and the appearance of a peak at 1710 cm
-1
 corresponding to the 
carboxylic acid generated (Fig.: 2.1 c). This process produced free carboxylic acid groups, 
which renders the nanoparticles pH-sensitive and potentially allows further biomodification 
of the nanoparticles. Newly formed carboxyl functionalized peptide silica hybrid particles 
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when dispersed in solutions of different pH values showed pH-responsive behaviour. This 
process is usually associated with helix-coil transition at pH 5.7. However, it has been 
shown that the transition point of end grafted poly(glutamic acid) shifts to the alkaline side 
suggesting that the grafted polymer favors the helical state.
50
 In contrast, when in an acidic 
pH environment, phase separation of the peptide chains occurs which results in aggregate 
formation. DLS studies of NP-g-PGA nanoparticles at different pH levels confirmed the 
above results. The hydrodynamic radius of completely solvated silica NP-g-PGA at pH 10 
was found to be 170 nm.  
It was hypothesized that PGA grafted silica nanoparticles could be employed for the pH-
triggered release of payload molecules. As a model system, the pH-directed release of 
hydrophobic rhodamine B was chosen to prove this concept. The entrapment of rhodamine 
B molecules within the hybrid structure was achieved by allowing the diffusion of 
rhodamine B into the hybrid particles at pH 2 at which the nanoparticles form aggregates. 
Confocal microscopy was utilized to demonstrate the ability of PGA decorated silica 
nanoparticles to release guest rhodamine B molecules as a result of an increase in the 
solution pH value. When immersed in a solution of pH 2 the dye is completely localized 
within the nanoparticle aggregates (Figure 2.6, left). From the image it cannot 
unambiguously been concluded whether the dye is entrapped within the aggregated 
nanoparticle structures or in the collapsed shell of the hybrid structure. However, the dye is 
clearly concentrated in the hydrophobic part of the hybrid clusters and cannot be removed 
by dialysis. Payload release is only achieved when the surrounding solution is replaced by 
one with a pH value capable of generating a swollen negatively charged PGA shell. In this 
instance a buffer solution of pH 10 was employed and the rapid diffusion of rhodamine B 
particles from the hosts’ interior occurred (Figure 2.6, right). This result signifies that the 
nanomaterials formed through the highly controlled NCA surface polymerization technique 
are therefore rendered pH-responsive and have the potential for use as pH-responsive 
payload delivery vehicles for the on-demand release of hydrophobic payloads.  
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Figure 2.6: Top: Confocal images of pH responsive entrapment and release of 
Rhodamine B from poly(glutamic acid) functional nanoparticles. Bottom: A schematic 
representation detailing the pH-triggered release of guest rhodamine molecules due to 
change in the hydrophilicity of the poly(glutamic acid) shell. Scale bars represent 
200 nm. 
 
The second concept, i.e. the availability of PGA grafted nanoparticles for bioconjugation, 
was proven by the attachment of green fluorescent protein (GFP) in PBS buffer using NHS 
coupling chemistry. The reaction solution was thoroughly washed after GFP conjugation to 
ensure the removal of all unbound GFP. The GFP conjugated nanoparticles were fully 
dispersible in water and fluorescent microscopy images taken from the nanoparticle 
solution after attachment of the GFP clearly show the green fluorescence (Fig. 2.7). It has 
to be noted that due to their small size individual nanoparticles cannot be visualized by this 
technique and cluster formation was intentionally promoted by using high concentrations in 
the sample preparation. The fluorescent particles visible in the image thus represent clusters 
of nanoparticles of otherwise dispersed GFP conjugated nanoparticles. 
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Figure 2.7:  Fluorescence Microscopy Image of Si NP-g-PLG-GFP conjugates.  
 
2.3 Conclusion 
 
The work detailed in this article suggests and validates a facile method for the grafting of 
polypeptide chains from the surface of amine-functionalized silica nanoparticles. Primary 
amine groups present on the nanoparticles were used to initiate the ring opening 
polymerization of the NCAs of BLG, PZLL and tBLC independently as homopolypeptides, 
and BLG and tBLC simultaneously to form a copolypeptide. The results suggest that this 
methodology for polymerization has the potential to be applied to other natural and non-
natural amino acids capable of forming an NCA as a technique to functionalize silica 
nanoparticles with a functional (co)polypeptide shell. All reactions gave a uniform and 
covalently bound polypeptide shell. Extensive washing of the silica nanoparticles prior to 
polypeptide grafting eliminated the production of non-covalently bound polypeptide in the 
final product, and thus enabled a very high grafting efficiency relative to previous studies. 
Further, the molecular weight of the polypeptide casing could be readily controlled by 
altering the monomer: initiator in the reaction with grafting densities around 0.4 chains per 
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nm
2
. Comparison between BLG grafting carried out at 0 °C and 20 °C suggested that the 
lower temperature afforded core-shell structures possessing hydrodynamic diameters that 
increased proportionally with increased BLG NCA in the monomer feed. TEM analysis 
confirmed that the structures formed possessed a core-shell inorganic-organic hybrid 
composition. We believe that this is the first time that such control has been demonstrated 
analytically for the grafting of polypeptides from silica nanoparticles. Deprotection of the 
benzyl ester from PBLG grafted silica nanoparticles gave rise to pH-responsive core-shell 
hybrid nanoparticles. Selective release of particle-entrapped rhodamine B molecules was 
demonstrated when the surrounding solution pH was changed from pH 2 to pH 10, offering 
a mechanism for the pH triggered release of payload molecules. Grafting of two or more 
peptides with side chains containing different functional groups may lead to multifunctional 
hybrid nanoparticles. 
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2.4 Experimental Section 
 
Materials: α-pinene 98%, bis(trichloromethyl) carbonate (triphosgene) 99%, tetraethyl 
orthosilicate (TEOS) puriss 99%, aminopropyltriethoxy silane (APTS), hydrobromic acid 
solution (HBr/AcOH) purum 33% in acetic acid (AcOH), Hydrofluoric acid (HF) 48 wt % 
in water, dimethylformamide (DMF) (anhydrous), ethyl acetate (anhydrous), chloroform 
(CHCl3), ethanol and n-heptane were purchased from Sigma-Aldrich and used without any 
further purification unless otherwise stated. γ-Benzyl-L-glutamate (BLG), N6-
Carbobenzyloxy-L-lysine (ZLL) and S-tert-butyl-L-cysteine (tBLC) were supplied by 
Bachem and converted into the corresponding NCAs following a literature procedure.51 
Dialysis membrane, Spectra/Por 6 (molecular weight cut-off: 1000 Da) was supplied by 
Spectrum Labs. Laboratory grade diethyl ether was purchased from VWR. DMF and ethyl 
acetate were stored under an inert, dry atmosphere.  
 
Methods: 
1
H and 
13
C nuclear magnetic resonance (NMR) spectra were recorded at room 
temperature with a Bruker Avance 400 (400 MHz) and a Bruker Avance Ultrashield 600 
(600 MHz). CDCl3 was used as solvent and the signals were referred to the signal of 
residual protonated solvent signals. Tetramethylsilane (TMS) was used as an internal 
standard for CDCl3. Elemental Analysis was performed on a CE440 Elemental Analyser 
from Exeter Analytical. A Perkin-Elmer Spectrum 100 was used for collecting attenuated 
total reflectance Fourier transform infrared (ATR-FTIR) spectra in the spectral region of 
650−4000 cm−1. The spectra were obtained from 4 scans with a resolution of 2 cm−1. A 
background measurement was taken before the sample was loaded onto the ATR unit for 
measurements. TEM images were obtained using a JEOL 2100 TEM scan instrument (at an 
accelerating voltage of 200 kV) for samples deposited on carbon-coated (400 mesh) copper 
grids. The preparation of samples for transmission electron microscopy (TEM) analysis 
involved depositing a drop (15 μL) of the nanoparticle solution in CHCl3, onto the grids 
and allowing the solvent to evaporate prior to imaging. All confocal microscopy 
experiments were carried out at room temperature. A Zeiss LSM 510 confocal microscope 
with an Ar
+
 laser was employed to visualize the release or entrapment. A 63x oil immersion 
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objective was used with an NA of 1.4. The excited light (514 nm) was passed through an 
80/20 beam splitter. Collected light was passed through an 80/20 beam splitter to a 560 nm 
dichroic filter. Following this the reflected light was further filtered with a 505 nm longpass 
filter and the transmitted light filtered with a 575 nm longpass filter. The pinhole size used 
was 60 μm. Image analysis was performed using Image J software. The dynamic light 
scattering (DLS) experiments of peptide grafted nanoparticles in different pH solutions 
were performed at 25 °C on a Zetasizer Nano ZS particle analyzer (Malvern Instruments) 
using a detection angle of 173° and a 4 mW He−Ne laser operating at a wavelength of 633 
nm. Size exclusion chromatography (SEC) analysis using DMF (0.1M LiBr) as eluent was 
done using PSS GRAM analytical (300 and 100 Å, 10μ) columns on an Agilent 1100 series 
equipped with a Wyatt Optilab rEX refractive index detector thermostated at 40 °C and a  
Wyatt DAWN HELEOS-II multi angle light scattering detector (MALS). Molecular 
weights and polydispersity index (PDI) were calculated from the MALS signal by the 
ASTRA software (Wyatt) using a dn/dc value of 0.118 mL/g for PBLG in DMF.
52
 Before 
SEC analysis was performed, the samples were filtered through a 0.2 μm PTFE filter (13 
mm, PP housing, Whatman). 
The grafting density of APTS (GAPTS) and PBLG (GPBLG) was calculated following a 
literature procedure using data from TAG analysis and the molecular weights of the 
degrafted PBLG.
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 The following equations were applied where W% is the weight loss 
between 150 and 800 °C from TGA analysis, Mn is the number average molecular weight 
of degrafted PGLG from GPC analysis, Ssp is the surface specific area of the nanoparticle 
and NA is Avagadro’s number. Ssp was calculated using the density of silica (2.27 g/cm
3
) 
under the assumption of a sphere: Ssp = 132 nm
2
/g for APTS functionalized nanoparticles 
(radius = 62 nm) and Ssp = 101 nm
2
/g for PBLG grafted nanoparticles (radius = 68 nm). 
 
 

GAPTS 
W%SiAPTS
100 W%SiAPTS

W%Si
100 W%Si





 MAPTS  Ssp





 NA

GPBLG 
W%PBLGSiAPTS
100 W%PBLGSiAPTS

W%SiAPTS
100 W%SiAPTS





 MnPBLG  Ssp





 NA
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Synthesis of silica nanoparticles: Silica nanoparticles were obtained by the Stöber 
method.
54
 In a round bottom flask tetraethyl orthosilicate (16.90 g, 81.12 mmol) was mixed 
for 1 minute in 163.9 mL of ethanol. To this limpid, colourless, solution 13 mL of 28-30% 
ammonia solution was added (1 minute mixing). The solution turned into a dense milky 
suspension in 20 minutes (no mixing during this time). This solution was left for 10 days at 
room temperature and then used. The average particle size obtained by above procedure 
was 110-120 nm determined by DLS.  
 
Synthesis of amino functionalised silica nanoparticles: Bare silica nanoparticles (1 g) 
were dispersed in 10 mL ethanol by ultrasonication for 10 min. resulting in milky fine 
suspension. A 90 mL solution ethanol/water 95/5 V/V was acidified to pH 5.0 by adding 
acetic acid glacial 60 µL and then APTS 4.2 g (19 mM) was added dropwise. The resulting 
clear colorless solution was kept under magnetic stirring (400 rpm) during 5 min. at room 
temperature in order to allow hydrolysis to occur and to form reactive silanols.  
The bare silica nanoparticle suspension was added dropwise to the silanol solution under 
magnetic stirring and the resulting pale milky suspension was stirred at room temperature 
for 2h. The suspension was then centrifuged at 4830 RCF for 30 min. The supernant liquid 
was clear and colorless and the decanted solid was white. This solid was washed 3 times 
with ethanol, resuspended in anhydrous THF and acetone followed by centrifugation. 
Amino functionalized silica particles were then dried in vacuum oven at 110 °C for 1 h and 
stored in airtight container.   
 
Ring opening polymerization of NCA-BLG from silica nanoparticles: The 
polymerization was carried out with different weight ratios of NCA to silica nanoparticles. 
The following describes a typical procedure. Amino functionalized silica nanoparticles 
(100 mg) were added to a dry Schlenk tube containing NCA-BLG (217 mg, 0.828 mmol). 
The Schlenk tube was purged with dry nitrogen gas and placed in an aqueous salt solution 
maintained at 0 ºC. Anhydrous DMF (10 mL) was then injected into the tube and the 
mixture stirred for 96 h. The peptide-grafted particles were then precipitated into cold and 
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dry diethyl ether (200 mL) before being washed four times with dry diethyl ether. These 
peptide grafted silica nanoparticles were then washed with 10 mL THF, centrifuged and the 
final nanoparticle solution (2 mL) was then precipitated in 25 mL diethyl ether. The 
particles were then washed twice with dry diethyl ether to remove traces of THF and dried 
under vacuum before being stored in the refrigerator. Yield: 185 mg. 
 
Ring opening polymerization of NCA-ZLL from silica nanoparticles: Amino 
functionalized silica nanoparticles (100 mg) were added to a dry Schlenk tube containing 
NCA-ZLL (200 mg, 0.653 mmol). The Schlenk tube was purged with dry nitrogen gas and 
placed in an aqueous salt solution maintained at 0 ºC. Anhydrous DMF (10 mL) was then 
injected into the tube and the mixture stirred for 96 h. The peptide-grafted particles were 
then precipitated into cold and dry diethyl ether (200 mL) and washed with dry diethyl 
ether and 10 mL THF and centrifuged. The procedure was repeated three times and the final 
nanoparticle solution (2 mL) was then precipitated in 25 mL diethyl ether. The particles 
were then washed twice with dry diethyl ether to remove traces of THF, and dried under 
vacuum before being stored in refrigerator. Yield: 165 mg. 
 
Ring opening polymerization of NCA-tBLC from silica nanoparticles: Amino 
functionalized silica nanoparticles (100 mg) were added to a dry Schlenk tube containing 
NCA-tBLC (100 mg, 0.425 mmol). The Schlenk tube was purged with dry nitrogen gas and 
placed in an aqueous salt solution maintained at 0 ºC. Anhydrous cold CHCl3 (10 mL) was 
then injected into the tube and the mixture stirred for 96 h. The peptide-grafted particles 
were then precipitated in cold, dry diethyl ether (200 mL) before being washed with dry 
diethyl ether and 10 mL CHCl3 and centrifuged. The procedure was repeated four times and 
the final nanoparticle solution (2 mL) was then precipitated in 25 mL diethyl ether. The 
particles were then washed twice with dry diethyl ether to remove traces of CHCl3, and 
dried under vacuum before being stored in the refrigerator. Yield: 130 mg.  
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Ring opening copolymerization of NCA-BLG/NCA-tBLC from silica nanoparticles: 
Amino functionalized silica nanoparticles (100 mg) were added to a Schlenk tube. NCA-
BLG (174.3 mg, 0.662 mmol) and NCA-tBLC (38.97 mg, 0.166 mmol) were then added to 
the nanoparticles. The Schlenk tube was purged with dry Nitrogen gas and placed in an 
aqueous salt solution maintained at 0 ºC. Anhydrous cold CHCl3 (10 mL) was then injected 
into the tube and the mixture was stirred for 96 h. The peptide-grafted particles were then 
precipitated in cold and dry diethyl ether (200 mL). The obtained precipitated particles 
were washed with dry diethyl ether and 10 mL THF and centrifuged. The procedure was 
repeated three times and the final nanoparticle solution (2 mL) was then precipitated in 25 
mL diethyl ether. The particles were then washed twice with dry diethyl ether to remove 
traces of THF, and dried under vacuum before being stored in refrigerator. Yield: 185 mg. 
 
Deprotection of silica NP-g-PBLG: PBLG grafted Silica nanohybrids (100 mg) were 
stirred in 5 mL HBr/AcOH (33% HBr in AcOH) solution for 3 h. This mixture was then 
precipitated in 50 mL cold diethyl ether. The resultant deprotected poly(glutamic acid) 
grafted silica nanoparticles (silica Np-g-PGA) were then washed with fresh diethyl ether 
four times to ensure the complete removal of deprotecting reagents. Yield: 75 mg. 
 
Deprotection of silica NP-g-PZLL: PZLL grafted Silica nanohybrids (100 mg) were 
stirred in 5 mL HBr/AcOH (33% HBr in AcOH) solution for 3 h. This mixture was then 
precipitated in 50 mL cold diethyl ether. The resultant deprotected poly(Lysine) grafted 
silica nanoparticles (NP-g-PLL) were then washed with fresh diethyl ether four times to 
ensure the complete removal of deprotecting reagents. Yield: 75 mg.  
 
Rhodamine B loading of silica NP-g-poly(L-glutamic acid): Silica NP-g-PGA 
nanoparticles (50 mg) were dispersed in a 5 mL solution of rhodamine B (2 mg/10 mL) at 
pH 2. The solution was stirred for 2 h to allow diffusion of the dye into the peptide shell. 
The rhodamine B loaded nanoparticle solution was then dialyzed in a 1,000 Da molecular 
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weight cut off membrane against a pH 2 solution for 3 days to ensure the complete removal 
of adsorbed rhodamine B on the particle surface if any. The dye-loaded particles were then 
separated from the supernatant by centrifugation (6,000 R.P.M for 30 minutes using a using 
a 6 x 2 mL centrifuge rotor).  
 
Etching of the silica core: In a Teflon vial, 0.5 mL of hydrofluoric acid solution was 
added to 3 mL dispersion of 10 mg PBLG grafted silica particles in THF and stirred 
overnight to ensure complete etching of silica by hydrofluoric acid. The reaction mixture 
was then added to polyethylene centrifuge tube and degrafted PBLG was precipitated by 
adding 10 mL deionized water followed by centrifugation at 9000 rpm for 10 min. Traces 
of HF was then removed by dissolving degrafted material in 0.5 mL THF and re-
precipitation in 5 ml deionized water. The product was then centrifuged at 6000 rpm for 5 
min. Repetitive washings and centrifugation were done with fresh deionized water until the 
washing solution had shown the same pH as the deionized water used for washing. The free 
polymer was dried in vacuum oven at 40 
0
C to remove traces of water. Yield: 1.5 mg. 
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Chapter 3 
 
Stable Aqueous Dispersions of Glycopeptide 
Grafted Magnetic Nanoparticles of Selectable 
Functionality 
 
 
 
 
 
This chapter has been published in Angew. Chem. Int. Ed. 2013, 52, 3164-3167 
Measurement of the magnetic properties of nanoparticles has been performed in Dr. 
Brougham’s laboratory.  
63 
 
Abstract 
 
Surface initiated NCA ring opening polymerization from spherical surfaces is a robust 
technique to graft high density polypeptide shell onto nanoparticle core. The ‘grafting-
from’ NCA ring opening polymerization of clickable amino acid and its subsequent click 
glycosylation to produce aqueous suspensions of glycopeptide grafted magnetic 
nanoparticles is presented. The novel materials have high sugar density, optimal dispersion 
and T1-weighted MRI properties, and bio-recognition ability. The approach can be used to 
attach any type or combination of functionalities and the density of functional groups is not 
limited by particle surface area. 
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3.1 Introduction 
 
Bio-nanomaterials have received increasing attention over the last decade, due to their 
potential to advance medical science by providing novel solutions for disease diagnostics 
and treatment.
1
 However, the engineering of bio-nanomaterials imposes considerable 
challenges, as significant design criteria and properties, dictated top-down by the specific 
application, must be met. MRI-trackable magnetic nanoparticles (MNPs), and their 
assemblies, capable of targeting specific cell types, e.g. cancer cells, for image-guided 
treatment are increasingly being investigated.
2
 Typical design criteria for MNPs are of 
biomedical nature, including cellular selectivity (bio-recognition), extended blood 
circulation times and biocompatibility, there are also practical considerations such as 
processability and scalability. Additional, MRI specific criteria, include colloidal stability 
and high image contrast. The efficacy of a MNP suspension for generating contrast by 
enhancing, or suppressing, local MRI signal is quantified by the spin-lattice (r1) and spin-
spin (r2) relaxivities, respectively. These are the water relaxation enhancement per 
millimolar concentration of iron. For T1-weighting applications (localized signal 
enhancement), r1 must be high, and r2 and the ratio r2/r1 must be low. Particle aggregation 
increases the r2 value, so T1-weighting can only be achieved by ensuring full MNP 
dispersion and long-term colloidal stability. 
Monosaccharides offer colloidal stability through charge and steric interactions along with 
the possibility of cellular targeting and so have been used to stabilize MNPs. Recently 
MNP clusters were prepared by encapsulation of alkyl-stabilized MNPs using poly(maleic 
anhydride-alt-1-octadecene) followed by EDC coupling of aminated sugars.
3
 Detailed 
analysis of the effect of coating on cellular uptake showed that high grafting density is 
critical for avoiding non-specific cellular interaction. However, the encapsulation approach 
resulted in extensive aggregation, as is usually the case, limiting the possibility of T1-
weighting application. Aggregation was exploited in a recent report where clickable 
monosaccharides were used to stabilize MNP clusters using complex peptide linkers,3 
allowing differentiation of cancer cells by quantitative profiling of carbohydrate binding 
through changes in T2 (local signal suppression). In a prominent recent example, a range of 
phosphonate-functionalized sugars were used to fully disperse MNPs and the effect of 
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MNP size on the T1-weighting and hyperthermic properties in vitro were investigated.
4
 
However, only one sugar per linker was possible, limiting the total sugar density.  
Hence there is a need for platform technologies that maximize the surface density of 
functional monosaccharides while allowing full MNP dispersion. Multifunctional polymers 
have potential to address the first issue; there have been two recent reports of grafting-onto 
for MNP modification with glycopolymers. However, dispersion proved not to be possible. 
In the first example glycosylated polyacrylate was grafted onto silica-coated iron-oxide 
MNPs.
5
 While cellular uptake of the micron scale aggregates was confirmed, the magnetic 
component was quite dilute. In the second example some improvement in colloidal control 
was achieved using glucosylated poly(pentafluorostyrene) derivatives, to produce 
suspensions of hydrodynamic size (dhyd) ranging from 100–300 nm.
6
 However, the 
polydispersity index (PDI) from dynamic light scattering was quite high (>0.22) suggesting 
non-uniform particles.  
  
Scheme 3.1: Synthesis of glycopeptide-grafted magnetic nanoparticles GP-MNPs. 
Here we describe for the first time combination of a polymer grafting-from approach with 
glycosylation by click chemistry for preparing MNPs with high surface density of 
monosaccharides. We hypothesized that this would promote dispersibility and, based on the 
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important role of carbohydrates in cell interaction/recognition,
7
 introduce bio-recognition. 
The polymers are synthetic polypeptides and thus rely on natural degradable building 
blocks (amino acids). This is the first report of glycopeptide-grafted superparamagnetic 
Fe3O4 nanoparticles (GP-MNP), which exhibit excellent water dispersibility, optimal T1–
weighting properties and selective binding.  
 
3.2 Result and Discussion  
 
The synthetic protocol (Scheme 1) involves the preparation of highly crystalline Fe3O4 
MNPs using the surfactant-free non-hydrolytic organic phase method.
8
 The MNPs were 
further functionalized with 3-aminopropyl-trimethoxysilane (APTS), which has been show 
to be an efficient initiator in the polymerization of amino acid N-carboxyanhydrides from 
silica nanoparticles.
9
 After APTS decoration the MNPs were fully dispersible in non-polar 
solvents. The particle core diameter was calculated to be dcore = 8.3 ± 2.0 nm from 
Transition Electron Microscopy (TEM) images (Figure 1) with dhyd = 12.9 nm (PDI 0.14) in 
CHCl3. The surface amine initiated ring-opening polymerization of propargyl-L-glutamate 
NCA
10 
afforded polypeptide grafted MNPs with click-able alkyne groups. The success of 
the grafting process was verified by FTIR analysis; displaying distinct amide I and II bands 
at 1649 and 1544 cm
-1
, characteristic of the α-helical conformation, and by the glutamic 
ester carbonyl band at 1725 cm
-1
. Glycosylation was achieved by Huisgens' “click” reaction 
of azide-functionalized galactose to the surface bound poly(propargyl-L-glutamate). FTIR 
spectra (Fig.: 3.1) show strong galactose OH-signals at 3296 cm
-1
 suggesting a high 
galactose content in agreement with our previous studies.
11
  
67 
 
 
Figure 3.1: ATR-IR spectrum of (a) peptide grafted magnetic nanoparticles (b) 
glycopeptides grafted magnetic nanoparticles (GP-MNP). 
The resulting glycopeptide-grafted particles were easily dispersible in water, further 
highlighting the successful synthetic protocol and extensive glycosylation. In water we find 
dhyd = 15.5 nm (PDI 0.12) by DLS and this value did not change over a period of months. 
The low PDI values strongly suggest that the stable suspensions are composed of fully 
dispersed MNPs, critical for bio-application. This is consistent with the TEM analysis 
which showed excellent quality MNPs with particle core diameters dcore of 8.3 ± 2.0 nm 
(Fig.: 3.2). 
 
Figure 3.2: Representative transmission electron micrographs and statistical analyses for; 
(lhs) APTS functionalized Fe3O4 NPs (dTEM 8.8 ± 2.7 nm), and (rhs) GP-MNPs (dTEM 8.3 ± 
2.0 nm). The scale bars represent 50 nm. 
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Stability of suspensions in water and salt was confirmed by dynamic light scattering (Fig.: 
3.3 and Fig.: 3.4). As the serum suspensions are unsuitable for DLS, stability was 
confirmed by the complete absence of any aggregation over several months, as confirmed 
by eye and by Fe determination (Fig.:3.5).  
 
 
Figure 3.3: DLS data for a typical GP-MNP suspension (mM range) in pure H2O (red) and 
the same suspension re-analysed five weeks later (green). The hydrodynamic properties are 
unchanged. 
 
 
Figure 3.4: DLS data for a typical GP-MNP suspensions (mM range) in pure H2O (red) 
and the same suspension, at a concentration of 0.14 mM NaCl, after standing for four days 
(green). The hydrodynamic properties are unchanged. 
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Figure 3.5: Typical GP-MNP suspensions, at Fe = 0.25 mM, in pure water (left), in serum 
after 1 day (centre), and in serum after two months (right). 
 
The efficacy of GP-MNP dispersions for generating image contrast was studied primarily 
by fast field-cycling NMR relaxometry, or NMRD. The technique involves measurement of 
r1 as a function of field strength (and hence 
1
H Larmor frequency). The profiles provide 
insight into the magnetic order of the particles in the dispersion, using the 
1
H relaxation of 
water as a local probe.
12
 Specifically, NMRD provides information on the diffusion lifetime 
of the solvent in the particles environment (and hence core size), on the dynamics of the 
N anis), and 
on the saturation magnetization (Ms) of the particles. 
A typical NMRD profile of a GP-MNP dispersion is shown in Fig.: 3.6. The presence of a 
mid-frequency minimum is highly characteristic of superparamagnetic MNPs in 
suspension. The solid line included in Figure 2 is a simulation using SPM theory,
13
 which 
provides very good agreement with experimental data. The values obtained from this 
analysis are dcore = 10 nm (slightly higher than TEM), Ms = 59 emu.g
-1
anis = 1.6 GHz 
N = 16 ns. The low anisotropy energy and rapid Néel motion confirm the 
superparamagnetism, and hence dispersion, of the MNPs. SPM theory is known to produce 
slight overestimates in core size, but quantitative Ms values. 
12(a),14 
The slight mid-frequency 
discrepancy arises due to a change in the relaxation mechanism in this range, which has 
been described.
15 
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Figure 3.6: 
1H relaxation profile (■) and relaxivity ratios (●), recorded at 298 K in H2O, 
for a GP-MNP suspension, dhyd 15.5 nm (PDI 0.12). The solid line is a simulation generated 
using SPM theory,
[15]
 the parameters used were; dcore 10 nm, Ms 59 emu.g
-1
anis 1.3 
N 16 ns, see text. The upper inset shows the determination of relaxivity (■ r1 ) and 
(● r2), at 9.25 MHz. The lower inset is a T1-weighted image, recorded at 120 MHz. From 
the left; 0.0, 0.008, 0.04, 0.2, 1.0 mM Fe. 
The utility of the GP-MNP dispersions for MRI is demonstrated by the values of the 
relaxivities, r1 and r2. GP-MNP have high r1 of 16 s
-l
mM
-1
 and low r2 of 62 s
-l
mM
-1
 at the 
typical clinical frequency of 61 MHz (1.5 T), giving an r2/r1 ratio of 3.9. In particular the 
low ratio further demonstrates that GP-MNPs are fully dispersed in water without any 
aggregation. The relaxivities confirm the applicability of the suspensions for T1–weighted 
imaging at 60 MHz. Furthermore, the image, inset to Figure 6, demonstrates strong signal 
enhancement, under T1-weighting, at 120 MHz. Hence GP-MNP may be useful over the 
human clinical MRI range. The relaxivities also show that the polymer chains have 
minimal effect on the interaction of the magnetic moments with bulk water.  
Most known MNP-based positive contrast agents are of slightly smaller size and hence 
lower r2/r1, but also lower r1. Citrate stabilized MNP dispersions, of dhyd 7 nm were 
considered as T1-agents for MRI angiography, r1 10.9 s
-1
mM
-1
, r2/r1 is 2.4.
16
 The medium-
term stability in blood was an issue, presumably due to desorptive loss of citrate. 
PEGylated Fe3O4 MNPs of the same core size, from ligand exchange of oleate, were also 
considered,
17
 with similar results; r1 7.3 s
-1
mM
-1
, r2/r1 2.4. However, on increasing the 
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molecular weight of the polymer, as would be required for optimal steric stabilization and 
to achieve “stealth” effects in vivo, partial aggregation occurred, compromising the T1-
weighting properties. By comparison, in our case the larger core used results in a 
favourable increase in r1, partially offset by an increase in r2/r1, however the T1-weighting 
potential remains. The grafting-from/click-functionalization strategy provides a robust and 
adaptable chemistry ensuring optimal colloidal properties (i.e. preventing particle 
aggregation which is the key limitation for maintain good T1-weighting
17
) but also opening 
up new potential for targeting. In this regard it is important to emphasise that the surface 
chemistry we have described can be used for any APTS coated iron oxide or metal ferrite 
MNP of any size.  
To demonstrate specific targeting we used galactose functionalized GP-MNP for binding to 
Ricinus communis Agglutinin (RCA120) lectin.
18
 Fig.: 3.7 shows that a magnet has no effect 
on the GP-MNP dispersion in water (~1.5 mM) due to the small size of the dispersed 
particles. The addition of RCA120 causes particle aggregation through selective multivalent 
binding with the lectin and attraction to the magnet. When additional galactose was added 
to the aggregated particles competitive binding with free galactose resulted in the re-
dispersion of MNPs. When the same experiment was carried out with Concanavalin A 
lectin (Con A), which is selective for glucosyl and mannosyl but unable to bind galactosyl 
residues, no aggregation was observed, highlighting the specific binding properties of the 
GP-MNPs.  
 
 
Figure 3.7: Dispersion of glycopeptide grafted MNPs in water (1-2 mM) before (A) and 
after the addition of lectin RCA120 (B). The addition of lectin causes particle aggregation 
through selective multivalent binding and attraction to the magnet (arrow). (C) Re-
dispersion of MNPs through addition of free galactose. 
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It should be emphasized that there are no technical limits to the types, or indeed the 
combinations, of functional groups that can be used. This differentiates the current work 
from other approaches to fully disperse MNPs in water, which include stabilization with 
low or intermediate molecular weight ligands. The most prominent of the former are citrate 
stabilized dispersed MNPs, which have been assessed for clinical application,
16
 however 
desorption limited colloidal stability and there was no potential for targeting. MNP 
stabilization with bio-derived ligands of intermediate molecular weight and lower charge 
(properties that reduce macrophage uptake), can be achieved by exchanging alkyl ligands, 
on MNPs synthesized by the thermal decomposition, with bi-functional silanes
19 
or 
phosphate-modified PEG
18
. However, yields can be low and the ligand density is often 
limited, in some cases compromising water stability. More recently, we reported a novel 
grafting-to approach, using epoxy linker chemistry, for binding amine bearing polymers or 
amino acids, yielding fully dispersed MNP suspensions.
8(b)
 Polymerization and MNP 
phase-transfer (from THF to water) was achieved in a single step, which limited the 
possibility for targeting with active functionalities. Indeed those limitations provided the 
motivation for the approach presented here. 
 
3.3 Conclusion 
 
We have reported first time instance of glycopeptide decorated magnetic nanoparticles by 
‘grafting from’ technique.  The main advantage of these techniques is non-limited 
availability of functional groups unlike monolayerd nanoparticles.  Versatile azide-alkyne 
click to graft various sugars renders aqueous dispersiblity accompanied by   bio-recognition 
ability.  The particles showed exceptional dispersion properties   useful for MR imaging as 
T1-weighed contrast agents accompanied by prolonged stability in aqueous media.   
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3.4 Experimental Details 
 
All material were obtained from Sigma-Aldrich and used as received unless otherwise 
noted. All anhydrous solvents mentioned were stored under dry inert atmosphere. 
Laboratory grade diethyl ether was purchased from VWR. 1-Azido-1-deoxy-β-D-
galactopyranoside was synthesized according to a literature procedure.
11(a)
 
 
Methods: The TEM measurements were performed using TECNAI G2 TEM operating at 
an accelerating voltage of 120 kV. Attenuated total reflectance (ATR) infrared spectra were 
recorded on a Spectrum GX FT-IR System (Perkin Elmer; Norwalk, CT, USA), under 
accumulation of 8 scans using a ZnSe trough plate crystal. Dynamic light scattering (DLS) 
experiments were performed at 25 °C on a Malvern NanoZS (Malvern Instruments, 
Malvern UK) which uses a detection angle of 173°, and a 3 mW He-Ne laser operating at a 
wavelength of 633 nm. The hydrodynamic diameter and the polydispersity index (PDI) 
values were obtained using cumulants analysis. PDI values below 0.2 indicate a 
monodisperse suspension. The frequency dependence of the water 
1
H relaxation, at 25 °C, 
was recorded over the frequency range 0.01–20 MHz using a Spinmaster FFC- 2000 Fast 
Field Cycling NMR Relaxometer (Stelar SRL, Mede, Italy). The system operated at a 
measurement frequency of 9.25 MHz for 
1H, with a 90° pulse of 7 μs. A re-conditioned 
Bruker WP80 electromagnet was used at 40 and 61 MHz. T2 was measured using the 
CPMG pulse sequence. Total iron content was determined by ICP-AES using a Varian 
Liberty 220ICP. Suspensions were prepared for determination by acid dissolution. MRI 
images were recorded at 3T (120 MHz) using a gradient echo sequence with TE = 2.3 ms, 
TR 134 ms, flip angle 80
o
, voxel size 0.45x0.45x3.00 mm.  
 
Synthetic Procedures  
Synthesis of APTS functional Fe3O4 nanoparticles: Magnetite nanoparticles were 
synthesized using a modification of the method reported by Pinna et al.
20
 In a typical 
synthesis, Iron (III) acetylacetonate (2 g) and benzyl alcohol (20 mL) were placed in flask 
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and the mixture heated to reflux (200 C) for 7 h under nitrogen.  The resulting black 
brown nanoparticles were washed twice with ethanol using magnetic separator (Dynamag). 
APTS (50 L) in chloroform (2 mL) was added to wet Fe3O4 nanoparticles and tumbled for 
an hour. The nanoparticles were precipitated in methanol to remove excess APTES and 
redispersed in chloroform.  
 
Synthesis of γ–propargyl L-glutamate hydrochloride: Propargyl ester of glutamic acid 
was synthesized by literature procedure by Hammond et al
10
 with some modifications. In a 
250 mL three necks round bottom flask 5 g (34 mmol) L-glutamic acid and 165 mL 
propargyl alcohol was added. The mixture was stirred under nitrogen atmosphere and 
refluxed at 40 C.  Over 1 hour 8.64 mL (64 mmol) chlorotrimethylsilane was added drop 
wise to this mixture and stirred overnight until all glutamic acid solid disappears. This clear 
reaction mixture was precipitated in diethyl ether and washed with fresh diethyl ether until 
a white solid was obtained.  This crude product was then purified to remove traces of 
propargyl alcohol by refluxing in anhydrous ethanol at 40 C and precipitation in diethyl 
ether.  Propargyl glutamate hydrochloride thus obtained was washed with diethyl ether and 
dried under vacuum. Yield - 6.48 g (86%). 
1
HNMR (400 MHz, D2O) = 2.20 (m, 2H, CH2), 
2.63 (dt, 2H, CH-CO), 2.86 (t, 1H, C≡CH), 3.99 (t, 1H, CH), 4.70 (d, 2H, CH2CO) 
 
Synthesis of N-carboxyanhydride of γ-propargyl -L-glutamate: NCA-PLG was 
synthesized following the procedure from Poche et al
21
 with minor modifications. To 
anhydrous ethyl acetate (50 mL), γ-propargyl-L-glutamte (1.5 g, 6.13 mmol) was added and 
refluxed at an ambient temperature. After addition of triphosgene (0.61 g, 2.04 mmol) the 
reaction mixture was refluxed for 5 hours under nitrogen atmosphere. The clear reaction 
mixture was cooled to 4 C in a fridge and washed with water (50 mL), saturated sodium 
bicarbonate (50 mL) and brine solution (50 mL) all cooled to 4 C.  The organic solvent 
was dried with magnesium sulphate and evaporated to get viscous oil. Yield - 0.82g (54%). 
1
H NMR (400 MHz, CDCl3)  δ=2.10-2.36 (dm, 2H, CH2), 2.53 (t, 1H, C≡CH), 2.62 (t, 2H, 
CHCO), 4.4 (t, 1H, CH), 4.72 (d, 2H, CH2CO), 6.2 (s, 1H, NH). 
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Grafting of polypropargyl-L-glutamate from MNP-APTS surface: To 250 mg NCA-
PLG in a Schlenk tube, 5 mL suspension of amino functionalised magnetic nanoparticles 
(MNP-APTS) (15 mg/mL) in anhydrous chloroform was added under nitrogen atmosphere. 
The reaction mixture was stirred for 72 hours at room temperature and completion of 
polymerization reaction was confirmed with ATR-IR spectroscopy. Poly(propargyl 
glutamate) grafted magnetic nanoparticles were precipitated in excess diethyl ether and 
separated as dry product.  The dry magnetic particles were suspended in an anhydrous 
DMSO (5 mL) and stored at room temperature under nitrogen atmosphere for further use. 
 
Glycosylation of Polypropargyl glutamate grafted magnetic nanoparticles (GP-MNP): 
In a Schlenk tube, to 5 mL suspension of PPLG grafted magnetic nanoparticles (1.12 mmol 
alkyne, considering 100% conversion of monomer to polymer and 100% grafting of 
polymer on MNP surface) in an anhydrous DMSO, 1-azido-1-deoxy-B-D-
galactopyranoside (344.5 mg, 1.68 mmol, 1.5 equiv to alkyne) and triethylamine (78.05 µL, 
0.56 mmol, 0.5 equiv to alkyne) were added. The suspension was degassed by purging dry 
nitrogen gas for 30 min. After addition of triphenylphosphine copper(I) bromide 
((PPh3)CuBr) (104 mg, 0.112 mmol, 0.1 equiv of alkynes) the reaction mixture was purged 
again with nitrogen for 30 min. The reaction mixture was then stirred at 30 C for 72 hours 
by placing in oil bath. Glycosylated magnetic particles were then precipitated twice in 
anhydrous THF (30 mL) and recovered by magnetic capturing. To remove traces of click 
catalyst and DMSO, GP-MNPS’s were further washed three times with fresh THF (20 mL). 
Dry GP-MNP’s were then suspended in DI water to make suspension of desired 
concentration and store in fridge.    
Lectin Binding Experiment: In a typical lectin binding experiment, to a 0.5 mL (~1.5 
mM) suspension of glycosylated magnetic nanoparticles in DI water, 100 µL (2 mg/mL) 
Lectin from Ricinus communis (castor bean) Agglutinin RCA120 was added resulting in 
instantaneous aggregation of nanoparticles. Addition of excess free galactose (100 µL (10 
mg/mL)) resuspends the nanoparticle to form homogeneous suspension.  A control 
experiment was performed with addition of 100 µL (2 mg/mL) Concanavalin A 
from Canavalia ensiformis (Jack bean) to the nanoparticle suspension.   
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Chapter 4 
 
Glycopeptide Grafted Magnetic Nanoparticles with 
Combined Targeting, siRNA Loading and Imaging 
Properties 
 
 
 
 
 
 
(Manuscript in preparation) 
 Measurement of the magnetic properties of nanoparticles has been performed in Dr. 
Brougham’s laboratory.  
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Abstract  
 
 A novel approach to design glyco-polypeptide grafted superparamagentic iron oxide 
nanoparticle MRI contrast agents with vector ability for anionically charged biomolecules 
such as siRNA has been described. These glyco-polypeptide grafted iron oxide 
nanoparticles have excellent aqueous dispersibilty applicable for T1- weighted positive 
magnetic resonance imaging. These hybrid nanoparticles display high positive ζ potential 
useful for siRNA complexation arsing from its poly(lysine) component whereas glycan 
mediated specific bio-recognition ability from glycosylated polypeptide component. This 
approach can be used to design new theranostics with choice of targeting ligands owing to 
ease of variety of coupling chemistry possibilities. 
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4.1 Introduction 
 
Next generation nanomedical devices require the development of new smart materials that 
combine several functionalities in one component. Combined diagnostic modalities of the 
diseased tissue and targeted therapeutic delivery are desired elements of ‘one package’ 
materials referred to as theranostics.
1,2
 The challenge in the development of these materials 
lies in the efficient packaging of imaging, targeting and therapeutic elements on the 
nanoscale.
3
 Particularly promising is the combination of magnetic resonance imaging 
(MRI) trackable nanoparticles with functional polymers as it allows compatibilizing the 
different functions by careful molecular design.
4,5,6
  
Superparamagnetic iron oxide nanoparticles (SPIONs) have recently drawn increased 
interest as MRI agents due to their low cytotoxicity.
7,8
 Maximum contrast through localized 
signal enhancement (T1-weighting) can be achieved by ensuring full MNP dispersion and 
long-term colloidal stability.
9
 Colloidal stabilization of SPIONs by surface modification 
with hydrophilic molecules including polymers has been reported but none of them have an 
active role in targeting or drug delivery.
10
 Glycosylated polypeptide-based materials show 
considerable promise as they are directly modelled on natural glycoproteins.
11
 The latter 
play a significant role in various physiological and pathological events, which makes 
glycochemistry an attractive tool in the design of materials for active targeting.
12
 We have 
recently disclosed a new concept combining MNP imaging with targeting by grafting 
glycosylated (galactose) polypeptides from the MNP surface.
13
 These particles displayed 
exceptional colloidal stability, selective binding ability towards glycan specific lectins and a 
potential to employ as T1 weighed MRI contrast agents. 
Herein we report the efficient synthesis of novel colloidal theranostic nanoparticles with 
combined MRI contrast function, selective binding and siRNA carrying properties. The 
synthetic protocol, using controlled surface polypeptide synthesis, permits extensive control 
over the positioning of targeting and drug cargo compartments so as to obtain an optimized 
molecular design. 
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Scheme 4.1: Schematic representation of PLL, PLL-b-(PPLG-c-Gal) and PLL-r-(PPLG-c-
Gal) grafting from APTS functionalized iron oxide nanoparticles. a. NCA-(Fmoc-L-lysine), 
b. NCA-(propargyl-L-glutamate), c. 1-Azido-1-deoxy-β-D-galactopyranoside. 
 
 
82 
 
4.2 Result and Discussion 
 
MNPs were functionalized with polypeptides comprising two different amino acids, namely 
lysine for siRNA binding
14
, and propargyl glutamate for attachment of galactose by click 
chemistry.
15,16
 The weight composition of the lysine to propargyl glutamate in the grafted 
polypeptide was kept 4:1 to design polypeptide with higher cationic charge density as it 
was envisioned that few sugar will be sufficient for lectin specific targeting and to enhance 
water dispersibility. In order to compare the influence of molecular architecture two distinct 
arrangements were targeted with the same polypeptide weight composition. In the first one 
both amino acid NCA were polymerized simultaneously resulting in a statistical 
arrangement of both amino acids on the MNP surface (Scheme: 4.1). In the second 
arrangement a block structure was targeted with PLL forming the inner block and the 
glycosylated PPLG the outer block. While the statistical structure is synthetically more 
straightforward, it was rationalized that a block structure would provide distinct 
compartments for siRNA polyplexes close to the MNPs surface surrounded by glycosylated 
periphery available for interaction with biological receptors.  
Statistical copolymerization was carried out with NCA of fluorenylmethyl-oxycarbonyl 
protected L-lysine (NCA-FLL) and NCA of propargyl-L-glutamate (NCA-PLG) (4:1 w/w) 
from aminopropyl trimethoxysilane (APTS) functional iron-oxide nanoparticle surfaces (8 
nm) at room temperature. ATR-IR analysis of the resulting nanoparticles confirmed the 
successful grafting of the polypeptides evident from the presence of a propargyl alkyne 
band at 2127 cm
-1
 and a characteristic Fmoc carbonyl band at 1693 cm
-1
 (Fig.: 4.1a). 
Notably, propargyl ester carbonyl band (1733 cm
-1
) and Fmoc carbonyl bond bands were 
merging in this statistical arrangement. Block co-polypeptide PFLL-b-PPLG were grafted 
from the magnetic nanoparticles by sequential addition of the monomers at 0 C to prevent 
termination reactions.
17
 PFLL was chosen as the first block and after 24 h complete 
monomer conversion was confirmed by ATR-IR by the absence of anhydride peaks at 1772 
and 1880 cm
-1
. The second monomer, NCA-PLG, was then added to form the second 
block. Analogous to the statistical copolymers, ATR-IR spectra displayed two defined 
peptide bands characteristic of the PPLG ester carbonyl (1733 cm
-1
) and a less intense band 
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for the Fmoc-carbonyl (1693 cm
-1
) of PFLL (Fig.: 4.2 b). When analyzed by TGA, the 
statistical copolypeptide (PFLL-s-PPLG ) showed organic content of 80 %  (Fig.: 4.3) 
whereas the nanoparticles containing the first poly(Fmoc-L-lysine) block, i.e. MNP-g-
PFLL, revealed a weight loss of 67.0 % between 150 to 650 °C accounting for the PFLL 
shell. After polymerization of the second propargyl-L-glutamate block (PFLL-b-PPLG) the 
organic content raised to 80 % (Fig.: 4.4). This is in an agreement with the targeted block 
length ratio of 4:1.  
 
Figure 4.1: ATR-IR Spectrum of (a) MNP-g-PFLL-s-PPLG (b) MNP-g-PLL-s-PPLG-c-
Gal. 
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Figure 4.2: ATR-IR Spectrum of (a) MNP-g-PFLL (b) MNP-g-(PFLL-b-PPLG) (c) MNP-
g-(PLL-b-(PPLG-c-Gal)). 
 
Figure 4.3: Thermogravimetric analysis of MNP-g-(PLL-s-(PPLG-c-Gal)) at various 
modification stages as MNP-g-(PFLL-s-PPLG) and MNP-g-(PLL-s-(PPLG-c-Gal)) 
indicated by black and red line, respectively. 
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Figure 4.4: Thermogravimetric analysis of MNP-g-(PLL-b-(PPLG-c-Gal)) at various 
modification stages as MNP-g-PFLL, MNP-g-(PFLL-b-PPLG) and MNP-g-(PLL-b-
(PPLG-c-Gal)) indicated by black, red and green lines respectively. 
The propargyl-L-glutamate of both statistical and block decorated MNPs were glycosylated 
with azido galactose using copper catalyzed Huisgen’s click chemistry. Because of the 
good solubility of the catalyst ((PPh3)3CuBr) and practically no solubility of the sugar in 
THF, repeated dispersion in DMSO and precipitation in THF was applied to remove all 
traces of copper catalyst. In a subsequent step, Fmoc was removed from PFLL by addition 
of pipyridine to the MNP suspension in DMF. The final products MNP-g-(PLL-s-(PPLG-c-
Gal)) and MNP-g-(PLL-b-(PPLG-c-Gal)) were then recovered as dry products by 
lyophilization. TGA analysis of the final product MNP-g-(PLL-b-(PPLG-c-Gal)) revealed 
an organic content of 70 % (Fig.: 4.4). This overall decrease in organic content (~10%) 
after glycosylation (theoretical addition of 40 wt%) and Fmoc deprotection (theoretical 
removal of 52 wt%) is in agreement with the NCA-PFL to NCA-PLG feed ratio (200 mg to 
50 mg respectively) suggesting quantitative glycosylation. TGA analysis of statistical 
statistical copolymer grafted magnetic nanoparticles revealed similar results. When 
analyzed by DLS, the poly(lysine)-b-glycopeptide decorated magnetic nanoparticles 
showed a hydrodynamic radius (dhyd) of ~18 nm (Fig.: 4.5) and a PDI of 0.08, similar to 
poly(lysine) functional magnetic nanoparticles. The particle core diameter of both block 
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and statistical glyco-polypeptide grafted  MNP’s was calculated to be (8.2 ±2.0) nm based 
on TEM analysis. This difference is due to the fact that the polypeptide shell is in a 
hydrated and extended state for the DLS analysis while it is dry and collapsed in the TEM 
analysis. Both glycol-polypeptide grafted MNP’s reveal excellent water dispersibility, 
which is prime requirement for the use as MRI contrast agents. 
 
Figure 4.5: DLS data for hydrodynamic size determination of iron oxide nanoparticles 
decorated with MNP-g-(PLL-b-(PPLG-c-Gal)) (green) and MNP-g-(PLL-S-(PPLG-c-Gal)) 
(red). 
 
Figure 4.6: Representative transmission electron microscopy images of  (a) MNP-g-(PLL-s 
-(PPLG-c-Gal)) and (b) MNP-g-(PLL-b-(PPLG-g-Gal)) grafted iron oxide nanoparticles. 
Inset shows zoomed images of well dispersed nanoparticles. The scale bar is 100 nm. 
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The efficiency of the poly(lysine)-co-glycopeptide (statistical and block) magnetic 
nanoparticles dispersions for generating image contrast in MRI was studied by fast field-
cycling NMR relaxometry (NMRD).
18
 Analysis of Fig.: 4.7 shows that the NMRD profiles 
possess a characteristic shape confirming superparamagnetic behaviour of the particles. 
However, the clear differences suggest that incorporation of glycopeptide into the 
stabilising polymer has a significant effect on the low frequency relaxation. The frequency 
of the maximum, which is known to be largely affected by the size of the inorganic core, is 
constant (~8 MHz) which suggests the size of the magnetic core remains unchanged across 
the different samples. At high fields there is only a small increase in relaxivity (r1) when the 
stabilising polymer is changed from PLL to PLL-s-(PPLG-c-Gal) to PLL-b-(PPLG-c-Gal). 
However, at the r1 maximum, and at low frequency there are significant differences in the r1 
values; in this frequency range the relaxivity is largely determined by the saturation 
magnetization, Ms, and the Néel relaxation processes (magnetic moment reorientation) and 
hence is sensitive to the magnetocrystalline anisotropy. As the particles are fully dispersed 
these observations suggest that the ligands alter both Ms and the characteristic Néel 
correlation time, N, of the individual particles. This is an unusual observation that requires 
some consideration. Simulation of the NMRD responses is ongoing in our collaborators 
laboratories.  
 
Table 4.1: Physical properties of MNP dispersions. 
 
 
 
 
 
 
 
MNP sample 
size (PDI) 
[nm] 
 
[mV] 
Relaxivity at 16.3mHz 
r1; r2; r2/r1 
[s
-1
mM
-1
] 
Relaxivity at 61 mHz 
r1; r2; r2/r1 
[s
-1
mM
-1
] 
PLL 18.5 (0.18) 56 136.22;98.31;2.71 17.89;80.87;4.51 
statistical 14.9 (0.12) 47 38.59;80.65;2.09 16.23;70.53;4.34 
block 18.5 (0.09) 31 42.68; 81.09;1.9 16.91;78.08;4.6 
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Figure 4.7 H
1
 relaxation profile and relaxivity ratios recorded at 298 K in H2O, for a MNP-
g-PLL (□), MNP-g-(PLL-s-(PPLG-c-Gal)) (●) and MNP-g-(PLL-b-(PPLG-c-Gal)) (○) 
suspensions, dhyd=18.5 nm (PDI 0.09). 
Zeta (ζ) potential measurement of these glycopeptide-co-poly(lysine) grafted iron oxide 
nanoparticles revealed accumulative positive charge slightly lower than pure poly(lysine) 
grafted nanoparticles (Table 4.1) offering vector ability for anionically charged 
biomolecules.  Small interfering RNA (siRNA) was used as model biomolecule to 
demonstrate vector ability of these glycopeptide-co-poly(lysine) grafted iron oxide 
nanoparticles.  Block glyco-polypeptide grafted MNP suspensions of varying volume (1-10 
µL) in DI water were mixed with fixed siRNA volume (1 µg) at increasing ratios and 
allowed to complex for 30 min. at room temperature.  Gel elctrophoresis assays were used 
to demonstrate and confirm the ability of these nano vectors to successfully complex  
anionically charged siRNA. In the gel retardation assay (Fig.: 4.8), lane 1 shows the siRNA 
reference band  whereas lane 2 shows complete complexation of siRNA with excess 
polyethylenimine (PEI) dendrimer, a commercial vector, by absence of siRNA band. In 
lanes 3 to 8 the fluorescence intensity of the siRNA band gradual decrease indicating an 
increasing complexation with increasing MNP/siRNA ratios. In lane 9 and 10 complete 
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complexation of siRNA with MNPs is evidenced by absence of a free (uncomplexed) 
siRNA band as also observed in case of excess PEI dendrimer (lane 2).  
 
Figure 4.8: Polyacryl-amide gel electrophoresis image of siRNA complexed MNP-g-(PLL-
b-(PPLG-c-Gal)) with increasing MNP amount. Lane 1 represents siRNA reference, lane 2 
represents PEI complexed siRNA  whereas  lane 3 to 10 represent  1, 2, 4, 6, 8, 10, 15, 20 
µL (2 mM) MNP suspension complexed with 1 µg siRNA respectively.  
 
Specific targeting was demonstrated by using galactose functionalized magnetic 
nanoparticles and galactose specific letin Ricinuscommunis Agglutinin (RCA120). As shown 
in Fig.: 4.9 a, an external strong magnet has no effect on the monodisperse aqueous 
dispersion of nanometer size magnetic nanoparticles (ca 1 mM). With the addition of the 
galactose specific lectin RCA120, instantaneous aggregation of the magnetic nanoparticles 
through selective multivalent binding with the lectin was seen. In a control experiment, 
galactose non-binding lectin Canavalia ensiformis (jack bean) Concanavalin A did not 
show any aggregation of nanoparticles confirming the specificity of these nanoparticles 
towards galactose specific lectins. To further visualise this effect, FITC was reacted to 
some lysine amino groups. FITC-labelled PLL-b-(PPLG-c-Gal)) grafted magnetic 
nanoparticles suspension also showed specific targeted binding towards RCA120 by 
displaying fluorescent aggregates when observed under UV light.  Addition of the aqueous 
solution of the free galactose to the aggregates resulted in redispersion of magnetic 
nanoparticles due to competitive binding of free galactose with the lectin. Similarly, 
successful complexation of siRNA with these glyco-polypeptide decorated nanoparticles 
was demonstrated using fluorescently tagged siRNA (Fig.: 4.10). The complexation with 
well dispersed nanoparticles displayed fluorescent aggregates capable of magnetic 
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capturing signifying increased total magnetization due to polyplexs formation (Fig.: 4.10 b 
(enhanced image)). The DLS analysis of these polyplexes revealed aggregates formation 
suggesting insufficient shielding of complexed siRNA by the glycopeptides block. Future 
studies of these siRNA delivery vehicles should focus on tailoring the length of outer 
glycopeptides shell to engineer the monodisperse siRNA vectors. 
 
 
Figure 4.9: Photographic images showing selective and reversible binding of fluorescently 
tagged MNP’s to lectin RCA120. 
 
Figure 4.10: RCA120 specific binding of fluorescently tagged si-RNA complexed MNP-
(PLL-b-(PPLG-c-Gal)) nanoparticles. (a) Si-RNA complexed nanoparticle dispersion in 
PBS buffer solution. (b) Magnetically captured nanoparticle aggregates after addition of 
RCA120. 
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4.3 Conclusion 
 
In conclusion, we have reported first instance of specific targeting superparamagnetic iron 
oxide nanoparticle useful for T1 weighed MR imaging with high positive ζ potential, 
capable of  siRNA complexation. The nanoparticles/siRNA complexes also showed 
specific binding towards targeted lectins highlighting their potential as theranostics. The 
ease of fluorescent tagging of nanoparticles could be useful for dual modal imaging. There 
is virtually no limit for the possibility of variety of sugar attachment or other clickable 
targeting moieties hence specific targeting due to versatility of the applied click chemistry.    
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4.4 Experimental Details 
 
Materials  
All material were obtained from Sigma-Aldrich and used as received unless otherwise 
noted.  All anhydrous solvents mentioned were stored under dry inert atmosphere. 
Laboratory grade diethyl ether was purchased from VWR. 1-Azido-1-deoxy-β-D-
galactopyranoside was synthesized according to a literature procedure.
19
  
 
Methods: The TEM measurements were performed using TECNAI G2 TEM operating at 
an accelerating voltage of 120 kV. Attenuated total reflectance (ATR) infrared spectra were 
recorded on a Spectrum GX FT-IR System (Perkin Elmer; Norwalk, CT, USA), under 
accumulation of 8 scans using a ZnSe trough plate crystal. Dynamic light scattering (DLS) 
experiments were performed at 25 °C on a Malvern NanoZS (Malvern Instruments, 
Malvern UK) which uses a detection angle of 173°, and a 3 mW He-Ne laser operating at a 
wavelength of 633 nm. The hydrodynamic diameter and the polydispersity index (PDI) 
values were obtained using cumulants analysis. PDI values below 0.2 indicate a 
monodisperse suspension. The frequency dependence of the water 
1
H relaxation, at 25 °C, 
was recorded over the frequency range 0.01–20 MHz using a Spinmaster FFC- 2000 Fast 
Field Cycling NMR Relaxometer (Stelar SRL, Mede, Italy). The system operated at a 
measurement frequency of 9.25 MHz for 
1
H, with a 90° pulse of 7 μs. A re-conditioned 
Bruker WP80 electromagnet was used at 40 and 61 MHz. T2 was measured using the 
CPMG pulse sequence. Total iron content was determined by ICP-AES using a Varian 
Liberty 220ICP. Suspensions were prepared for determination by acid dissolution. MRI 
images were recorded at 3T (120 MHz) using a gradient echo sequence with TE = 2.3 ms, 
TR 134 ms, flip angle 80
o
, voxel size 0.45x0.45x3.00 mm.  
 
Complexation of siRNA with MNP-g-PLL-b-(PPLG-c-Gal)): 
siGENOME non-targeting siRNA #4 (5’ AUGAACGUAAUUG-CUAA 3’) was obtained 
from Dharmacon and used in for complexation with iron oxide nanoparticles. The 
siRNA/MNP-g-PLL-b-(PPLG-c-Gal) complexes were prepared freshly prior to use. 
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Varying volume of PLL-b-(PPLG-c-Gal) grafted magnetic nanoparticle  solution of known 
iron content ( ca.2 mM in DI water) (1, 2, 4, 6, 8, 10, 15, 20 µL) was used for complexation 
with fixed quantity of siRNA (1 µg) in tris HCl buffer (pH 7.4) (25 µL ). The incubation 
was done at room temperature for 30 min. 
 
Gel Retardation Assay: 
Above prepared MNP-PLL-GP/siRNA complexes were mixed with loading dye (Promega 
G190A-Blue/orange 6x) and analysed by running 20% non denaturating polyacryl-amide 
gel in TBE buffer at 100 V for 1 h. Upon completion, the gel was stained using Gelstar 
nuclic acid gel stain for 30 min. Visual images were then obtained by UV transillumination 
(G. Box, Syngene, UK).   
 
Lectin Binding Experiment:  
(a) MNP-g-(PLL-b-(PPLG-c-Gal)): In a typical lectin binding experiment, to a 0.5 mL ( 
ca.2 mM) suspension of glycosylated block co-polypeptide grafted magnetic nanoparticles 
in DI water, 100 µL (2 mg/mL) Lectin from Ricinus communis (castor bean) Agglutinin 
RCA120 was added resulting in instantaneous aggregation of nanoparticles. Addition of 
excess free galactose (5 mg) resuspended the nanoparticle to form homogeneous 
suspension.  A control experiment was performed with addition of 100 µL (2 mg/mL) 
Canavalia ensiformis (jack bean) Concanavalin A to the nanoparticle suspension.  
(b) Fluorescently tagged MNP-g-(PLL-b-(PPLG-c-Gal)): Above set of experiments was 
performed with fluorescently labelled MNP-g-(PLL-b-(PPLG-c-Gal)) nanoparticles by 
coupling fluorescein isothiocyanate  (FITC) to amines groups of poly(lysine) shell. 
Magnetic nanoparticle suspension (2 mL, ca. 2 mM) was stirred with FITC solution in 
DMSO (5µL, 1mg/mL) in dark conditions at room temperature. Traces of unbound FITC 
were removed by dialysis prior to lectin binding experiment. 
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(c) Fluorescently tagged siRNA complexed MNP-g-(PLL-b-(PPLG-c-Gal)): Magnetic 
nanoparticle dispersion in DI water (250 µL, 2 mM,) was allowed to complex with 
fluorescently tagged siRNA (2 µg) for 30 mins at room temperature. ) Lectin from Ricinus 
communis (castor bean) Agglutinin RCA120 (50 µL, 2 mg/mL) was added to the siRNA 
complexed nanoparticle suspension which resulted in instantaneous aggregation  The 
nanoparticle suspension before and after addition of lectin was viewed and photographed in 
the presence of UV light. 
 
Synthetic Procedures  
Aminopropyltriethoxysilane functional Fe3O4 nanoparticles (MNP-APTS): Magnetite 
nanoparticles were synthesized using our previously reported method.13 In short, the 
mixture of  Iron (III) acetylacetonate (2 g) and benzyl alcohol (20 mL) was  refluxed (200 
C) in round bottom flask under nitrogen for 7 hrs.  The resulting black brown 
nanoparticles were washed twice with ethanol using magnetic separator (Dynamag). 
APTES (50 L) in chloroform (2 mL) was added to wet Fe3O4 nanoparticles and tumbled 
for an hour. The nanoparticles were precipitated in methanol to remove excess APTES and 
redispersed in chloroform.  
 
Synthesis of N-carboxyanhydride of Fmoc-L-lysine (NCA-FLL): The NCA-FLL was 
synthesized using literature procedure reported by Gijs et al
20
 with some modifications. In a 
250 mL three necks round bottom flask Nε-ﬂuorenylmethoxycarbonyl-L-lysine  (5.00 g, 
13.6 mmol) and  α-pinene (4.28 g, 31.4 mmol) was added to dry anhydrous ethyl acetate 
(60 mL) . The mixture was stirred under nitrogen atmosphere and heated to reflux.   
Triphosgene  (2.72 g, 9.17 mmol) ethyl acetate (20 mL) was added drop wise to this 
mixture over 30 min and refluxed overnight until all solid disappears. This clear reaction 
mixture was reduced to 1/3 by evaporating ethyl acetate and immediate precipitation was 
seen after addition of 40 mL n-heptane. The mixture was heated to clear solution and 
allowed to cool slowly. The precipitated NCA was filtered, washed with n-heptane, dried 
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under vacuum to yield NCA (4.10 g, 76.6%) as a white powder and stored in fridge for 
further use.  
1
H-NMR (400 MHz, CDCl3, δ, ppm): 7.77 (d, 2H, ArH, J = 7.5 Hz), 7.59 (d, 2H, ArH, J = 
7.5 Hz), 7.40 (t, 2H, ArH, J = 7.2), 7.31 (t, 2H, ArH, J = 7.2), 6.68 (s, 1H, NH), 4.85 (s, 1H, 
NH), 4.44 (t, 2H OCH2CH, J = 6.0), 4.29 (t, 1H, CHC(O), J = 5.4 Hz), 4.21 (t, 1H, 
CHCH2O, J = 6.5 Hz), 3.18 (m, 2H, CH2NH), 1.96 (m, 2H,CH2CH), 1.53 (m, 2H, CH2), 
1.42 (m, 2H, CH2) 
13
C-NMR (100 MHz): 169.9 (OC(O)CH), 153.8 (C(O)NH), 152.5 
((CO)NH), 143.8 (Ar), 141.3(Ar), 127.7 (Ar), 127.1 (Ar), 125.0 (Ar), 120.0 (Ar), 66.7 
(CH2O), 57.4 (CH), 47.2 (CH), 40.0 (CH2), 30.8 (CH2), 21.3 (CH2). 
 
Synthesis of N-carboxyanhydride of propargyl glutamate (NCA-PLG):  The NCA-PLG 
was synthesized by our previously reported procedure.
13
  
  
MNP-g-PLL: To the NCA-FLL (200 mg) in a Schlenk tube, 2 mL suspension of amino 
functionalised magnetic nanoparticles (MNP-APTS) in anhydrous chloroform was added 
under nitrogen atmosphere. The reaction mixture was stirred for 24 h at room temperature 
and completion of polymerization reaction was confirmed with ATR-IR spectroscopy. 
Poly(Fmoc-L-lysine) (PFLL) grafted magnetic nanoparticles were precipitated in excess 
diethyl ether and separated as dry product.  To a suspension of above mentioned magnetic 
particles in anhydrous DMSO (3 mL), piperidine (1 mL) was added drop wise to deprotect 
poly(Lysine) (PLL) side chain amine groups.  The suspension was stirred for another 2 
hours followed by precipitation in anhydrous diethyl ether to get PLL grafted magnetic 
nanoparticles.  These nanoparticles were then dispersed in water and the pH of the 
suspension was adjusted to acidic (~4-5) by adding 1M HCl. The suspension was then 
dialyzed against water to remove piperidinium salt traces and excess acid. The PLL grafted 
iron oxide nanoparticles suspension was then sized and stored in a fridge.        
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MNP-g-(PFLL-s-PPLG): The NCA-FLL (200 mg) and NCA-PLG (50 mg) were weighed 
in a clean dry Schlenk tube to which MNP-APTS suspension in CHCl3 (2 mL) was added 
under nitrogen atmosphere. The reaction mixture was stirred at room temperature to which 
1 mL anhydrous DMSO was added after initial 15 minutes to improve the dispersibility of 
newly forming MNP-polypeptide hybrids. The reaction was stirred for 24 h and an 
exhaustion of monomer feed was confirmed by ATR-IR. MNP-g-(PFLL-s-PPLG) hybrids 
were then obtained as a dry powder by precipitating in diethyl ether. 
 
MNP-g-(PFLL-b-PPLG): In a clean dry Schlenk tube NCA-FLL (200 mg) was weighed 
to which MNP-APTS suspension in CHCl3 (2 mL) was added under nitrogen atmosphere at 
0 
o
C in thermostat and stirred for 24 hrs. An aliquot (0.2 mL) was taken out after 
confirming the complete exhaustion of monomer added by ATR-IR. In a sequential step, a 
solution of NCA-PLG (50 mg) in an anhydrous DMSO (1 mL) was added to Schlenk tube. 
The reaction mixture was stirred at 0 
o
C for another 24 hrs time by which the complete 
conversion of second monomer added to polypeptide occurred confirmed by ATR-IR. 
MNP-g-(PFLL-b-PPLG) hybrids were then recovered as a dry powder by precipitating in 
diethyl ether. 
 
Glycosylation of block and statistical PFLL-co-(PPLG) grafted magnetic 
nanoparticles and subsequent Fmoc deprotection: Copper catalyzed Azide Alkyne Click 
(CuAAC) was used for glycosylation of alkyne moieties of polypeptide shell as we reported 
previously
13
 with minor modifications. Exact procedure was followed for both block and 
statistical co-polypeptide grafted magnetic nanoparticles. In a Schlenk flask, to 5 mL 
suspension of PFLL-b-PPLG grafted magnetic nanoparticles (0.237 mmol alkyne, 
considering 100% conversion of monomer to polymer and 100% grafting of polymer on 
MNP surface) in an anhydrous DMSO, 1-azido-1-deoxy-B-Dgalactopyranoside (97 mg, 
0.473 mmol, 2 equiv. to alkyne) and N-N diisopropylethylamine (21 µL, 0.12 mmol, 0.5 
equiv to alkyne) were added. The suspension was degassed by purging dry nitrogen gas for 
30 min. After addition of triphenylphosphine copper(I) bromide ((PPh3)3CuBr) (44 mg, 
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0.047 mmol, 0.2 equiv of alkynes) the reaction mixture was purged again with nitrogen for 
30 min and left stirring for 48 h at room temperature. The glycosylated magnetic 
nanoparticles were then precipitated in anhydrous THF (50 mL). The dry nanoparticles 
were resupended in DMSO (5 mL) and reprecipitated in THF (50 mL) thrice to remove 
copper catalyst. To a catalyst free glycosylated magnetic particle dispersion in anhydrous 
DMSO ( 3 mL), piperidine (1 mL) was added dropwise and stirred for 2 hrs followed by 
precipitation in anhydrous diethyl ether.  The final product poly(lysine)-co-glycopeptide 
grafted magnetic nanoparticles were suspended in water by adjusting the solution pH to 
acidic (~ 4-5) by addition of 1 M HCl solution. Pipiredinium salt, acid traces and excess 
sugar was removed by dialysis against DI water.  Finally, the glycosylated co-polypeptide 
grafted MNPs were sized and stored in fridge for further use. 
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Synthetic polypeptides could be employed with organic/inorganic materials to create a new 
class of smart hybrid materials with improved biocompatibility and biodegradability. The 
bio-mimetic design of the synthetic polypeptides could potentially improve the bio-
interaction ability of these hybrids. Especially, glycosylated synthetic polypeptides are of 
great importance for bio-interaction due to their specificity in recognition towards lectins. 
These glycosylated polypeptides hybrids could find advanced applications in drug delivery, 
implants, tissue engineering combined with imaging properties. Glycopeptide grafted iron 
oxide nanoparticles with excellent dispersibility are a good example of this. The surface 
grafted glycopeptides component not only improved aqueous dispersion properties of 
nanoparticles but also retained its recognition abilities towards specific lectins. Further 
studies could aim at the attachment of other clickable sugars or interaction facilitating 
moieties onto the polypeptide backbone to investigate specific cell attachment and 
internalization.  
An increase in complexity of polypeptide component by polymerization of two or more 
amino acid NCA’s could be of interest to obtain hybrids with multiple functionalities. The 
advantage of good control over the structure and polydispersities of grafted polypeptides by 
SI-NCA-ROP technique could be useful for compartmentalization of the polypeptide shell 
by grafting defined block co-polypeptides. These hybrids with defined polypeptide shell 
compartments might be interesting for loading cargos such as drugs, DNAs, siRNAs, 
imaging agents could find applications in advanced theranostics whereas, 
compartmentalization of catalysts and enzymes could open their applications as 
nanoreactors.  A case study of poly(lysine)-b-glycopeptide grafted iron oxide nanoparticles 
as presented here is a first attempt towards grafting of defined polypeptide shell to create 
excellent water dispersible magnetic nanoparticles rendered with siRNA vector ability. In a 
further study, it is required to address the optimization of the glycopolypeptide shell 
thickness to provide efficient shielding of siRNA complexed with poly(lysine) inner shell 
to create monodisperse theranostic nanoparticles.  It should also be possible to exploit the 
current system by using small nucleotides to complex with poly(lysine) inner shell to check  
effectiveness of glycopeptide shell and craft monodisperse nanoparticles. Detailed 
biological studies will shine light on the applicability of these hybrids in living systems. 
